Quarterlytics / Technology / Software - Application / Aware / FY2014 Annual Report

Aware
Annual Report 2014

AWRE · NASDAQ Technology
Claim this profile
Ticker AWRE
Exchange NASDAQ
Sector Technology
Industry Software - Application
Employees 51-200
← All annual reports
FY2014 Annual Report · Aware
Loading PDF…
2014 Annual Report

 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION 
Washington, D.C. 20549 

FORM 10-K 
Annual Report Pursuant to Section 13 or 15(d) of The  
Securities Exchange Act of 1934

For the fiscal year ended December 31, 2014 

Commission file number 000-21129 
AWARE, INC. 

(Exact Name of Registrant as Specified in Its Charter) 

Massachusetts     

            (State or Other Jurisdiction of 
         Incorporation or Organization)

                        (I.R.S. Employer Identification No.) 

 04-2911026 

40 Middlesex Turnpike, Bedford, Massachusetts  01730
(Address of Principal Executive Offices) 
(Zip Code) 

(781) 276-4000 
(Registrant’s Telephone Number, Including Area Code) 

Securities registered pursuant to Section 12(b) of the Act: 

Title of Each Class                                               Name of Each Exchange on Which Registered 
Common Stock, par value $.01 per share          The Nasdaq Global Market 

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [  ]   No [X] 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. 
Yes [  ]  No [X] 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such 
filing requirements for the past 90 days.   

  Yes [X]     No [  ] 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File 
required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such 
shorter period that the registrant was required to submit and post such files).  Yes [X ] No [   ] 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to 
the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any 
amendment to this Form 10-K.  [X] 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  
See the definitions of "large accelerated filer”, “accelerated filer", and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one): 

Large Accelerated Filer___    Accelerated Filer_X_   Non-Accelerated Filer___ Smaller Reporting Company ___ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ]    No [X]  

As of June 30, 2014 the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant, based on the closing sale price 
as reported on the Nasdaq Global Market, was approximately $95,635,924.  

The number of shares outstanding of the registrant’s common stock as of February 5, 2015 was 22,865,565. 

DOCUMENTS INCORPORATED BY REFERENCE 

Portions of the registrant’s definitive Proxy Statement to be delivered to shareholders in connection with the registrant’s Annual
Meeting of Shareholders to be held on May 20, 2015 are incorporated by reference into Part III of this Annual Report on Form 10-K. 

 
 
   
       
   
            
   
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
FORM 10-K 
FOR THE YEAR ENDED DECEMBER 31, 2014 

TABLE OF CONTENTS 

PART I

Item 1. 
Item 1A. 
Item 1B. 
Item 2. 
Item 3. 
Item 4. 

Item 5. 

Item 6. 
Item 7. 

Item 7A. 
Item 8. 
Item 9. 

Item 9A. 
Item 9B. 

Item 10. 
Item 11. 
Item 12.  

Item 13. 
Item 14. 

Business ................................................................................................................................... 
Risk Factors ............................................................................................................................. 
Unresolved Staff Comments .................................................................................................... 
Properties ................................................................................................................................. 
Legal Proceedings .................................................................................................................... 
  Mine Safety Disclosures .......................................................................................................... 

PART II 

  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases 
of Equity Securities ..................................................................................................................
Selected Financial Data ............................................................................................................ 

  Management’s Discussion and Analysis of Financial Condition and Results  

of Operations ............................................................................................................................
Quantitative and Qualitative Disclosures About Market Risk ................................................. 
Financial Statements and Supplementary Data ........................................................................ 
Changes in and Disagreements with Accountants on Accounting and Financial 
Disclosure ................................................................................................................................
Controls and Procedures .......................................................................................................... 
Other Information .................................................................................................................... 

PART III 

Directors, Executive Officers and Corporate Governance ....................................................... 
Executive Compensation .......................................................................................................... 
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder 
Matters .....................................................................................................................................
Certain Relationships and Related Transactions, and Director Independence ......................... 
Principal Accountant Fees and Services .................................................................................. 

3 
14
20
20
20
20

21

23

24
37
38

62
62
62

63
63

63
63
63

Item 15. 

Exhibits and Financial Statement Schedule ............................................................................. 

64 

PART IV

Signatures ............................................................................................................................................................... 

66 

2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART I 

FORWARD LOOKING STATEMENTS 

Matters discussed in this Annual Report on Form 10-K relating to future events or our future performance, including 
any  discussion,  express or  implied,  of our  anticipated  growth,  operating  results,  future  earnings  per  share,  market 
opportunity,  plans  and  objectives,  are  “forward-looking  statements”  within  the  meaning  of  Section  27A  of  the 
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These 
statements  are  often  identified  by  the  words  “may,”  “will,”  “expect,”  “believe,”  “anticipate,”  “intend,”  “could,” 
“estimate,”  or  “continue,”  and  similar  expressions  or  variations.  Such  forward-looking  statements  are  subject  to 
risks,  uncertainties  and  other  factors  that  could  cause  actual  results  and  the  timing  of  certain  events  to  differ 
materially from future results expressed or implied by such forward-looking statements. Factors that could cause or 
contribute to such differences include, but are not limited to, those discussed in the section titled “Risk Factors,” set 
forth in Item 1A of this Annual Report on Form 10-K and elsewhere in this Report. The forward-looking statements 
in this Annual Report on Form 10-K represent our views as of the date of this Annual Report on Form 10-K. We 
anticipate that subsequent events and developments will cause our views to change. However, while we may elect to 
update these forward-looking statements at some point in the future, we have no current intention of doing so except 
to  the  extent  required  by  applicable  law.  You  should,  therefore,  not  rely  on  these  forward-looking  statements  as 
representing our views as of any date subsequent to the date of this Annual Report on Form 10-K. 

ITEM 1.   BUSINESS

Company Overview  

Aware, Inc. (“Aware”, “we”, “us”, “our”, or the “Company”) is a leading provider of software and services to the 
biometrics  industry.    We  have  been  engaged  in  this  business  since  1993.    Our  software  products  are  used  in 
government  and  commercial  biometrics  systems  to  identify  or  authenticate  people.  Principal  government 
applications of biometrics systems include border control, law enforcement, national defense, secure credentialing, 
access control, and background checks. Principal commercial applications include: i) user authentication for login to 
mobile devices, computers, networks, and software programs; ii) user authentication for financial transactions and 
purchases (online and in-person); iii) physical access control to buildings, and iv) screening and background checks 
of prospective employees and customers. 

Our  products  provide  interoperable,  standards-compliant,  field-proven  biometric  functionality  and  are  used  to 
capture, verify,  format,  compress  and  decompress  biometric  images  as  well  as  aggregate,  analyze, process,  match 
and  transport  those  images  within  biometric  systems.  We  sell  a  broad  range  of  software  products  for  fingerprint, 
facial,  and  iris  modalities. We  also offer  a variety  of  software  engineering  services,  including:  i) project planning 
and  management;  ii)  system  design;  iii)  software  design,  development,  customization,  configuration,  and  testing; 
and iv) software integration and installation. We sell our biometrics software products and services globally through 
systems integrators and OEMs, and directly to end user customers.  

Aware  was  incorporated  in  Massachusetts  in  1986.    We are  headquartered  at  40  Middlesex  Turnpike  in  Bedford, 
Massachusetts,  and  our  telephone  number  at  this  address  is  (781)  276-4000.    Our  website  address  is 
www.aware.com.  The information on our website is not part of this Form 10-K, unless expressly noted.  Our stock 
is traded on the Nasdaq Global Market under the symbol AWRE. 

Industry Background 

Biometrics is the measurement of unique, individual physiological characteristics, such as fingerprints, faces, irises, 
and voices that can be used to determine or verify an individual’s identity. The biometrics industry offers technology 
that  digitally  captures  and  encodes  biometric  characteristics  and  then  compares  those  characteristics  against 
previously  encoded  biometric  data  to  determine  or  verify  an  individual’s  identity.  Biometrics  addresses  the 
limitations inherent in traditional identification and authentication processes, such as paper credentials, passwords, 
PIN codes and magnetic access cards.  

The  biometrics  industry  provides  identification  solutions  for  a  broad  range  of  government  and  commercial 
applications.  Principal  government  biometrics  applications  include  border  control,  law  enforcement,  national 
3

defense, secure credentialing, access control and background checks.  Principal commercial applications include: i) 
user authentication for login to mobile devices, computers, networks, and software programs; ii) user authentication 
for  financial  transactions  and  purchases  (online  and  in-person);  iii)  physical  access  control  to  buildings;  and  iv) 
screening and background checks of prospective employees and customers. 

We believe that government and commercial entities will continue to adopt and expand the use of biometric-enabled 
solutions  to  address  the  limitations  and  vulnerabilities  of  traditional  identification  processes.  We  believe  the 
following  factors,  among  others,  will  contribute  to  the  growth  of  biometrics  solutions:    i)  government-mandated 
implementation  of  identification  for  employees,  citizens,  and  foreign  nationals  to  enhance  national  security;  ii) 
military  implementations  for  the  identification  of  terrorists  and  other  hostile  persons;  iii)  increasing  threats  to 
personal security encountered in areas such as transportation; iv) government and commercial efforts to detect and 
reduce fraud and cybercrime; and v) the emergence and adoption of international biometrics standards. 

The biometrics industry may be segmented into government and commercial sub-markets. While these markets are 
similar  in  many  respects  and  share  similar  characteristics,  other  aspects  of  the  markets  are  different.    Important 
factors that differentiate the government  market from the commercial  market include: i) principal applications; ii) 
solutions;  and  iii)  suppliers.  We  believe  that  this  market-based  distinction  is  important  to  an  understanding  of 
Aware’s business as the vast majority of our revenue is currently derived from government customers. 

Government market

Governments  were  early  adopters  of  biometrics  technology  and  currently  represent  the  largest  consumer  of  the 
technology.  There  are  sub-sectors  within  government,  such  as  state,  local  and  national,  that  use  biometric 
technology. For example, at the local law enforcement level, biometric technology permits more efficient criminal 
booking  and  processing  and  also  allows  officers  in  the  field  to  identify  potential  suspects  more  reliably  and 
efficiently.  Within  military  organizations,  two  key  applications  of  biometrics  involve:  i)  the  verification  and 
identification  of  military  personnel  and  contractors;  and  ii)  the  collection  and  processing  of  biometrics  from  non-
military personnel for the purpose of identifying potential hostile persons. State and local governments also benefit 
through  applications  such  as  background  checks,  the  provision  of  drivers’  licenses  and  identification  cards  and 
benefits issuance.  

At  the  national  level,  governments  throughout  the  world  have  taken  steps  to  improve  security  in  response  to 
heightened concerns over public safety from the threat of terrorism. National governments have mandated increased 
spending on security measures, implemented new regulations and placed greater emphasis on technology to address 
growing  security  concerns.  Agencies  responsible  for  immigration  and  border  management  use  biometrics  to  help 
establish the identity of visitors. For example, the U.S. Office of Biometric Identity Management currently requires 
foreign  visitors  entering  the  United  States  to  have  their  ten  fingers  scanned  and  a  digital  photograph  taken  to 
determine if they are present in a watch list. The European Union now mandates that e-passports include fingerprint 
data in addition to a digital photograph. The biometrics industry continues to benefit from these measures because 
biometric technology provides a reliable means of establishing and verifying identities.  

Government  biometrics  systems  typically  operate  on  client/server-based  computer  networks.    Enrollment 
workstations with peripheral capture devices are used to “enroll” individuals into biometrics systems.  Either fixed 
enrollment workstations or mobile devices are used to capture, process, and format biometric images. Those images 
are  then  transported  in  digital  form  to  centralized  matching  systems  for  identification.  Examples  of  capture 
peripherals  include  scanners  for  fingerprint  images,  cameras  for  iris  and  facial  images,  and  handheld  devices  for 
mobile  capture  of  fingerprint,  iris,  and  facial  images.    Other  hardware  components  used  in  biometrics  systems 
include computer servers to process and transport biometrics images and mainframe computers and servers to store 
and  match  those  images.  In  addition,  military  applications  may  employ  handheld  devices  that  are  capable  of 
capturing images and matching those images against image databases that reside on the devices. 

Due to the nature of government applications, particularly those involving security, government biometric systems 
must be capable of accurately and rapidly matching biometric images against large databases of stored images. The 
ability to accurately and rapidly match images against databases of millions of images is critical because incorrect or 
delayed  results  could  have  severe  adverse  consequences.  These  requirements  are  an  important  distinguishing 
characteristic of the government market as compared to the commercial market. 

There  are  a  number  of  vendors  that  serve  the  government  biometrics  market.    We  believe  these  vendors  may  be 
segmented into three types of suppliers:  

4

i) Technology  suppliers  –  Within  this  category,  there  are  suppliers  that  provide  software  and  hardware 

technologies that enable biometrics systems.  

Biometrics  software  products  provide  functionality  that:  i)  captures  and  formats  images;  ii)  processes  and 
transports images, and iii) matches images. Companies that sell products in this category include: i) Aware; ii) 
Cognitec  Systems  GmbH  (“Cognitec”);  iii)  Neurotechnology;  iv)  Iritech,  Inc. (“Iritech”);  v)  Innovatrics  s.r.o. 
(“Innovatrics”); vi) WCC Group B.V. (“WCC”); vii) Daon, Inc. (“Daon”); viii) M2Sys Technology (“M2Sys”); 
and ix) Agnitio S.L. (“Agnitio”). 

Hardware companies that provide equipment used in biometrics systems include: 

(cid:120)

Biometrics-specific hardware vendors, such as: i) Cross Match Technologies, Inc. (“Cross Match”); ii) Iris 
ID Systems, Inc.; iii) Integrated Biometrics, LLC (“Integrated Biometrics”); and iv) Lumidigm, Inc. which 
was acquired by HID Global Corporation in 2014 (“HID/Lumidigm”); and  

(cid:120) General purpose computer hardware companies, such as Hewlett-Packard Development Company, L.P. and 

Dell, Inc.  

ii) System  integrators  –  This  category  of  suppliers  includes  companies  that  provide  system  integration  services. 
System  integrators  purchase  hardware  and  software  from  biometrics  technology  vendors,  such  as  those  listed 
immediately  above.    They  then  incorporate  those  components  into  customized  biometrics  systems  that  they 
build  for  their  end-user  customers.    System  integrators  include  large  multinationals  with  a  broad  range  of 
expertise and the capacity to execute very large projects, as well as smaller system integrators that have more 
focused expertise on a particular market sector, technology, or geography. 

Examples of systems integrators include: i) Northrop Grumman Corporation; ii) Lockheed Martin Corporation; 
iii)  Science  Applications  International  Corporation;  iv)  Hewlett-Packard  Enterprise  Services;  v)  International 
Business Machines; vi) Fujitsu Limited; vii) Computer Science Corporation; vii) Accenture plc; vii) Raytheon 
Company;  ix) Unisys Corporation; x) Unicom Government, Inc; and xi) Telos Corporation.  

iii) Fully  integrated  solutions  vendors  –  This  category  of  suppliers  includes  companies  that  are  fully  integrated 
providers of biometric systems.  Such companies combine their in-house hardware and software technologies 
with  their  systems  integration  services  to  deliver  customized  biometrics  systems  to  their  end-user  customers. 
While these vendors may purchase some components from third parties, we believe such component purchases 
represent a minor portion of the total systems they deliver. 

We  believe  there  are  three  primary  fully  integrated  solutions  vendors.    They  are:  i)  MorphoTrak  and 
MorphoTrust, divisions of the Safran Group Company (“Safran Morpho”); ii) 3M Cogent Inc. (“3M/Cogent”); 
and  iii)  NEC  Corporation  (“NEC”).    We  believe  that  these  companies  supply  a  large  percentage  of  the 
government market. 

Commercial market 

Although  the  recent  appearance  of  biometric  readers  on  popular  consumer  products,  such  as  smartphones,  has 
increased interest in biometrics as a means of authenticating and/or identifying individuals, commercial markets for 
biometrics  technology  are  in  the  process  of  developing  and  evolving.      Biometrics-based  solutions  compete  with 
more  traditional  security  methods  including  keys,  cards,  personal  identification  numbers  and  security  personnel. 
Acceptance of biometrics as an alternative to such traditional methods depends upon a number of factors including: 
i)  the  performance  and  reliability  of  biometric  solutions;  ii)  costs  involved  in  adopting  and  integrating  biometric 
solutions; iii) public concerns regarding privacy; and iv) potential privacy legislation. 

Principal  biometrics  applications  in  commercial  markets  involve  the  authentication  and/or  identification  of 
individuals.  Examples of such applications include:  

(cid:120) User authentication for login and access to mobile devices, computers, networks, and software programs. 
(cid:120) User authentication for financial transactions in the financial services industry. 
(cid:120) User authentication for in-person or online purchases in the retail industry. 
(cid:120) Authentication for physical access to secured buildings and perimeters. 
(cid:120) Authentication of employees to access private patient information in the healthcare industry. 
(cid:120) Authentication of test takers in the educational testing industry. 
(cid:120)

Identification of prospective customers in the financial services industry. 

5

(cid:120)
(cid:120)
(cid:120)

Identification of candidates for pre-employment screening and background checks. 
Identification of patients in hospital and surgical settings. 
Identification of undesirable customers in the gaming industry. 

The  types  of  users  that  may  need  to  be  authenticated  or  identified  in  commercial  applications  include  customers, 
employees,  suppliers,  visitors,  patients,  or  other  parties  wishing  to  gain  access  to  information,  systems,  bank 
accounts, credit card accounts, events, devices, buildings, or organizations.  

We believe that the commercial biometrics market may be further delineated into mobile and enterprise segments 
although that distinction is not always clear as the two segments may overlap. Notwithstanding that limitation, this 
distinction serves a useful purpose in describing commercial biometrics markets as of the end of 2014. 

Mobile  segment  -  The  mobile  segment  is  dominated  by biometrics-enabled  smartphones. Many  smartphones  now 
contain fingerprint sensors and software that can: i) enroll and encode a fingerprint image, ii) store the image in a 
secure  area  on  the  phone,  and  iii)  collect  a  live  fingerprint  and  match  it  to  the  stored  fingerprint  image.  Once  a 
biometric match is achieved, the subsequent software functions are analogous to password authentication.  This type 
of  biometric  authentication  is  sometimes  referred  to  as  a  “1-to-1”  match.  Such  1-to-1  matches  require  less 
algorithmic accuracy, speed, sensor fidelity, and computer processing power than “1-to-many” matches that are used 
in government or enterprise applications that employ large databases of stored images. 

Mobile  biometrics  authentication  applications  are  largely  controlled  by  smartphone  manufacturers  as  this 
functionality  is  executed  by  smartphone  operating  systems  and  hardware,  as  opposed  to  third-party  applications 
running on the phone. Applications running on smartphones are currently granted access to biometric authentication 
results,  but  may  not  necessarily  have  access  to  raw  biometric  samples,  hardware,  relevant  security  functions,  or 
other smartphone capabilities. User authentication using facial or voice biometric modalities may be implemented in 
applications running on the phone, because these applications can make use of the camera and microphone on the 
device.  User authentication and payment features enabled by smartphones continue to evolve, and we expect to see 
further changes in smartphone functionality.  

Enterprise  segment  -  Enterprise  biometric  systems  typically  provide  for  more  robust  performance  than  can  be 
achieved on smartphones. Enterprise systems have greater power, functionality, flexibility, and control than mobile 
systems.  Similar  to  government  biometrics  systems,  enterprise  solutions  typically  operate  in  a  client/server 
environment  that:  i)  captures  biometrics  images  on  a  client  PC;  ii)  stores  those  images  in  a  large  database  on  a 
server,  and  then,  when  queried;  iii)  matches  live  samples  against  stored  images.    As  with  passwords,  there  are  a 
variety of mechanisms that may be used to secure the privacy of biometrics stored on servers. Mobile systems may 
be  used  in  conjunction  with  enterprise  systems,  and  we  believe  that  evolving  smartphone  biometric  functionality 
will likely have an impact on enterprise-centric biometrics systems in the future.  

Another  model  for  enterprise  biometric  authentication  employs  smart  cards  for  storage  of  reference  biometric 
images. In this model, a user must possess a smart card that contains a stored biometric image in order to achieve 
authentication. 

There are standardization efforts being conducted by various industry consortia that may contribute to the adoption 
of biometrics for user authentication, with each tending to focus on a particular aspect of user authentication. These 
include FIDO Alliance (password enhancement), Natural Security Alliance (credit card enhancement), and NSTIC, 
or Natural Strategy for Trusted Identities in Cyberspace (access to online services). International standards bodies 
such  as  the  Internationals  Standards  Organization  (ISO)  will  likely  also  play  a  role  in  developing  standards  for 
biometric  user  authentication.    Today,  these  standards  are  in  various  stages  of  completion,  and  adoption  can  be 
generally considered as nascent. 

Classifying commercial biometrics hardware and software suppliers into well-defined mobile/enterprise categories is 
an  imperfect  exercise  as:  i)  commercial  markets  are  evolving;  ii)  some  suppliers  are  involved  in  mobile  and 
enterprise  segments;  and  iii)  some  suppliers  sell  multiple  types  of  products,  including  hardware,  software,  or 
hardware  products  containing  software.  Subject  to  this  limitation,  the  following  paragraphs  provide  examples  of 
commercial biometrics vendors. 

Hardware suppliers include three principal types of vendors: 

(cid:120) Hardware companies involved in the mobile segment of the commercial  market. These companies include: i) 
Apple,  Inc.  through  its  acquisition  of  AuthenTec,  Inc.;  ii)  Synaptics,  Inc.,  which  is  a  supplier  to  Samsung

6

Electronics  Co.,  Ltd;  iii) Qualcomm  Technologies,  Inc.  through  its  acquisition of  UltraScan  Corporation;  and 
iv) Sonavation, Inc. 

(cid:120) Hardware companies involved in the enterprise segment of the commercial market.  These companies include: 
i)  DigitalPersona,  Inc.,  which  was  acquired  by  Francisco  Partners  Management  LLC  and  merged  with  Cross 
Match in 2014; ii) Integrated Biometrics; iii) HID/Lumidigm; iv) Fingerprint Cards AB; v) Suprema, Inc.; vi) 
Credence ID, LLC; vii) SecuGen Corporation; viii) Next Biometrics AS; and ix) Eyelock, Inc. (“Eyelock”).  

(cid:120) Hardware  companies  focused  on  the  access  control  segment  of  the  enterprise  commercial  market.  These 
companies include: i) Honeywell International, Inc.; ii) HID/Lumidigm; iii) Tyco International Ltd.; iv) Lenel 
Systems International Inc.; v) Stanley Security Limited; vi) IrisGuard, Inc.; and vii) Aurora Biometrics, Inc. 

Commercial biometrics software suppliers include: i) Aware; ii) M2Sys; iii) Iritech; iv) Precise Biometrics AB; v) 
Facebanx, a subsidiary of OhHi, Ltd; vi) Agnitio; vii) VoiceTrust GmbH.; viii) Eyelock; ix) BIO-key International, 
Inc.; x) VoiceVault Inc.; xi) EyeVerify, Inc.; xii) NexID Biometrics LLC; and xiii) Imprivata, Inc. 

In  addition  to  supplying  fully  integrated  solutions  to  government  biometrics  markets,  Safran  Morpho  and 
3M/Cogent also supply fully integrated biometrics solutions to commercial enterprise markets. 

Products and Services 

Software products 

We  sell  a  broad  range  of  biometrics  software  products  for  fingerprint,  facial,  and  iris  modalities.    Our  software 
products enable important functions in biometrics systems, including: 

Integration of peripheral biometric capture devices. 

1. Enrollment, analysis, and processing of biometrics images and data. 
2.
3. Centralized transaction workflow and processing. 
4. Matching of biometric images to verify identity or searching biometric databases; and 
5. Analysis and processing of text-based identity data. 

Our biometrics software products range from discrete software blocks that customers can use to develop their own 
solutions to more complete applications that customers can use to reduce or eliminate their development times. We 
classify  our  biometrics  software  products  into  four  product  groups,  including,  i)  Software  Development  Kits;  ii) 
BioComponentsTM;  iii)  Biometric  Applications;  and  iv)  Biometric  Services  Platform  (“BioSPTM”).    Each  of  these 
product groups is described below. 

1) Software  Development  Kits. Our  software  development  kits  or  (“SDKs”)  consist  of:  i)  multiple  software 
libraries;  ii)  sample  applications  that  show  customers  how  to  use  the  libraries;  and  iii)  documentation.  
Customers use our SDKs to design and develop biometrics applications. Our SDK products may be categorized 
into  three  groups:  i)  Enrollment;  ii)  Search  and  Matching;  and  iii)  Identity  Data  Management  and  Analytics. 
These products are described below. 

SDK Group 1: Enrollment SDKs.  Our suite of enrollment SDKs performs a variety of functions that are critical 
to  biometric  enrollment,  including  image  capture,  image  quality  assurance,  image  formatting,  and  image 
compression. Our enrollment SDK products include: 

(cid:120) Hardware abstraction, autocapture, and quality assurance products, including: i) FastCapture with LiveScan 
API;  ii)  PreFaceTM  with  Camera  API;  iii)  IrisCheckTM  with  IrisCam  API;  iv)  SequenceCheckTM;  and  v) 
Quality CheckTM.

(cid:120)

(cid:120)

(cid:120)

(cid:120)

Biometric data formatting, validation and reading products, including: i) NISTPack; ii) ICAOPack; and iii) 
PIVPackTM.

Fingerprint,  facial,  and  iris  image  compression  and  decompression  products,  including:  i)  Aware 
WSQ1000; and ii) Aware JPEG2000. 

Biometric authentication products, including AwareXMTM.

Fingerprint card scanning and printing products, including: i) AccuScanTM; and ii) AccuPrintTM.

7

(cid:120) Mobile  products  for  smartphones  and  tablets,  including:  i)  NISTPack  Mobile;  ii)  WSQ1000  Mobile;  iii) 

ICAOPack Mobile; iv) PIVPackTM Mobile; and v) AwareXMTM Mobile. 

(cid:120) Application specific bundles, including CaptureSuiteTM which is used for the development of applications 

for the capture of live scan or card scan fingerprint images. 

SDK Group 2: Search and Matching SDKs.  In 2014, we introduced our Nexa™ line of biometric search and 
matching products for fingerprint, facial and iris images, including our Nexa|Fingerprint™, Nexa|Face™, and 
Nexa|Iris™  products.    These  products  contain  algorithms  that  convert  images  into  biometric  templates.  A 
biometric template is a mathematical representation of a biometric image. Templates can then be compared to 
image templates stored in image databases to find matches. 

Each Nexa SDK can be deployed on a workstation or a server, either as a standalone biometric search/match 
API, or in combination with our other SDKs, applications, and BioSP product.  Our SequenceCheck, PreFace, 
and  IrisCheck  SDKs  may  be  used  in  concert  with  Nexa  libraries  to  perform  optional  quality  assurance  and 
preprocessing for enhanced fingerprint, face, and iris search and match functionality. 

SDK Group 3: Identity Data Management and Analytics SDK.  In 2014, we also introduced our INQUIRE™ 
(INformation  QUality  and  Identity  Resolution  Engine)  SDK  product.  INQUIRE  contains  algorithms  for  text-
based  filtering,  searching,  matching,  and  linking  functions  to  discover  useful  information  in  identity  data. 
Product  capabilities  include:  i)  integrating  and  resolving  identity-centric  data  across  multiple  data  stores;  ii) 
assessing data quality and detecting anomalies; iii) performing link analysis and relationship discovery; and iv) 
performing text-based pre- and post-filtering of biometric searches.  

2) BioComponents.  Our BioComponents products allow customers to develop biometric enrollment applications 
more quickly than if they purchased our SDKs.  Each product in the group includes a user interface and one or 
more  software  libraries  that  perform  a  discrete  set  of  functions,  such  as  automated  image  capture,  quality 
assurance,  and  capture  hardware  integration.    BioComponents  comprise  modular,  independent,  self-contained 
software  components  that  can  operate  either  independently  or  in  concert  with  one  another.    Specific 
BioComponents products and the functions they perform are: 

(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)

BiographicComponent enables highly configurable data entry of biographic and textual information. 
FingerprintComponent is used to capture, verify image quality, and compress fingerprint images. 
FaceComponent is used to capture, verify image quality, and manipulate facial images. 
IrisComponent is used to capture, segment, and verify image quality of iris images. 
TravelDocComponent is used to authenticate travel documents, such as passports and driver’s licenses. 
ScanningComponent is used to scan forms such as inked fingerprint cards. 
PrintingComponent is used for printing FBI-quality fingerprint images on cards and forms. 
SignatureComponent is used to collect handwritten signature images from an electronic signature pad. 
PackagingComponent allows access to the data sets from the other components. 

3) Biometric  applications.    Our  products  in  this  category  combine  user  interfaces  with  multiple  Aware  software 
libraries  and/or  BioComponents  to  create  more  complete  applications  that  operate  on  client  workstations  or 
mobile devices.  Our application products and the functions they perform are: 

(cid:120)

(cid:120)

(cid:120)

(cid:120)

(cid:120)

Universal  Registration  Client  (“URCTM”).  URC  is  a  configurable  Windows-based  application  that 
performs a variety of biometric data capture, analysis, matching, formatting, and hardware abstraction 
functions.  

URC  Mobile.  URC  Mobile  is  a  software  application  for  performing  biometric  enrollment, 
identification, and screening on mobile biometric devices, such as those used by military personnel in 
the field. 

FormScannerSE  and  FormScannerMB.    These  are  two  independent  applications  for  scanning  and 
processing of inked fingerprint cards. 

FormScannerSWFT.    This  product  is  a  version  of  FormScannerSE  that  is  preconfigured  for  use  in 
compliance  with  the  “Secure  Web  Fingerprint  Transmission”  program  of  the  U.S.  Department  of 
Defense. 

Forensic Workbench.  Forensic Workbench is a software application for the categorization, processing, 
and standards-compliant formatting of biometric images and demographic data. 

8

(cid:120)

Sequence  Workbench.  Sequence  Workbench  is  a  software  application  for  the  detection  and  assisted 
repair of fingerprint records containing sequence errors. 

(cid:120) WebEnroll.  WebEnroll  provides  a  reference  application  that  uses  BioComponents  for  browser-based 

enrollment of biographic data, fingerprints, facial images, and iris images. 

4) Biometric Services Platform (BioSP).  Our Biometric Services Platform, or BioSP product, is a service-oriented 
application  used  to  enable  biometric  data  processing  and  management.  BioSP  is  suited  for  applications  that 
require  the  collection  of  biometrics  throughout  a  distributed  network.    BioSP  is  designed  to  be  modular, 
programmable,  scalable,  and  secure.    It  is  used  to  manage  transaction  workflow,  including  messaging, 
submissions, responses, and logging. 

Key BioSP features and functionality include: 

automated biometric image and data analysis, processing, formatting, quality assurance, and reporting. 

(cid:120)
(cid:120) web services in support of a scalable, secure, service-oriented architecture. 
(cid:120)

integration of  biometric functions with other enterprise systems such as identity management, access 
management, card management, and AFIS/ABIS. 
1-to-1 and 1-to-many biometric matching for verification, identification, and duplicate checking. 
centralized system administration and user management. 
advanced reporting capabilities for fast troubleshooting of biometric capture problems. 
centralized configuration, distribution, and management of enrollment client software. 
support for fingerprint, facial, iris, and palm modalities. 

(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)

In  addition  to  our  biometrics  software  products,  we  also  sell  products  used  in  applications  involving  medical  and 
advanced  imaging.  Our  principal  imaging  product  is  Aware  JPEG  2000.    Our  JPEG  2000  image  compression 
software  may  be  used  for  a  variety  of  applications  where  compression  and  decompression  of  still  imagery  is 
required.  Sales of imaging software products represented 7% of total revenue in 2014. 

Software maintenance

We  also  sell  software  maintenance  contracts  to  many  of  our  customers  who  purchase  software  licenses.    These 
contracts  typically  have  a  one  year  term  during  which  customers  have  the  right  to  receive  technical  support  and 
software updates, if and when they become available.  Customers tend to renew maintenance contracts during the 
period of time that our software is being used in their biometrics systems. 

Services 

We  offer  a  variety  of  software  engineering  services,  including:  i)  project  planning  and  management;  ii)  system 
design; iii) software design, development, customization, configuration, and testing; and iv) software integration and 
installation.  Services are typically, but not always, sold in conjunction with software licenses.  

Service engagement deliverables may include: i) custom-designed software products; ii) custom-configured versions 
of existing software products; iii) one or more subsystems comprised of software products that are integrated within 
a larger system; or iv) complete software solutions.  In some cases, the software resulting from service engagements 
may form the basis for new or improved Aware software products.  

Our customers for services include: i) government agencies; ii) large multinational systems integrators; iii) smaller 
systems  integrators  with  a  particular  market,  technology  or  geographic  focus;  and  iv)  commercial  providers  of 
products,  solutions,  and  services.    We  provide  services  directly  to  end-users  or  indirectly  to  end-users  through 
systems integrators.  When we provide services to systems integrators, they are often engaged with the end-user as a 
prime  contractor  and  are  responsible  for  delivery  of  a  complete  solution,  in  which  case  we  typically  serve  as  a 
subcontractor assigned a subset of the total scope of work. 

The  scope  of  our  services  projects  varies.    A  small  project  might  involve  configuration  and  testing  of  a  single 
software product, taking a small team one month or less.  A large project might involve delivery of a more complex 
solution  comprised  of  multiple  products  and  subsystems,  requiring  a  larger  team  to  conduct  project  management, 
system  design,  software  customization  and  integration,  and  taking  up  to  one  year  or  more.    Some  projects  are 
followed by subsequent projects that serve to change or extend the features and functionality of the initial system.   

9

Hardware products 

We  developed  a  biometrics  software  system  for  a  U.S.  government  customer  under  a  Small  Business  Innovation 
Research (“SBIR”) contract that began in 2008 and ended in early 2013.  When the software development project 
ended in early 2013, we entered into a separate contract to supply hardware products incorporating the developed 
software.    Hardware  products  sold  to  this  customer  integrate  the  developed  software  with:  i)  hardware  purchased 
from  third  parties;  ii)  software  purchased  from  third  parties;  and  iii)  some  of  our  biometrics  software  products.  
While other customers could theoretically purchase the hardware products developed for this customer, we believe 
that it is unlikely that they will do so, because of the highly customized nature of the products.   

Sales and Marketing 

As of December 31, 2014, we had a total of 11 employees in our sales and marketing organization. In addition to our 
employee sales staff, we also engage third party sales agents to represent our products in various foreign countries.  

We sell our products and services through three principal channels of distribution: 

i)

Systems  integrator  channel  –  we  sell  to  systems  integrators  that  incorporate  our  software  products  into 
biometrics systems that are delivered primarily to government end users. 

ii) OEM channel – we sell to hardware and software solution providers that incorporate our software products 

into their products.   

iii) Direct channel – we also sell directly to government, and, to a lesser degree, to commercial customers.  

All of our revenue in 2014, 2013, and 2012 was derived from unaffiliated customers. Revenue from the U.S. Navy 
represented 24%, 21%, and 5% of total revenue during 2014, 2013, and 2012, respectively. Revenue from the U.S. 
Marine Corps represented 10%, 3%, and 0% of total revenue during 2014, 2013, and 2012, respectively. No other 
customer represented 10% or more of total revenue in any of those years.   

Competition 

The markets for our products and services are competitive and uncertain.  We compete against: i) other companies 
that  provide  biometric  software  solutions;  and  ii)  fully  diversified  companies  that  provide  biometric  software 
solutions  and  also  act  as  systems  integrators.  We  can  give  no  assurance  that:  i)  our  products  and  services  will 
succeed  in  the  market;  ii)  that  we  will  be  able  to  compete  effectively;  or  iii)  that  competitive  pressures  will  not 
seriously harm our business.   

Many  of  our  competitors  are  larger  than  us  and  have  significantly  greater  financial,  technological,  marketing  and 
personnel resources than we do.  At the other end of the competitive spectrum, we have seen increasing competition 
from  smaller  biometrics  companies  in  foreign  countries.  These  smaller  foreign  competitors  have  demonstrated  a 
willingness to sell their biometrics software products at low prices.  

We can give no assurance that our customers will continue to purchase products from us or that we will be able to 
compete effectively in obtaining new customers to maintain or grow our business. 

Aware’s Strategy 

Our strategy is to capitalize on our strong brand and reputation to sell biometrics software products and services into 
government and commercial markets.  We intend to offer a broad portfolio of high quality products that are coupled 
with expert technical support and services.  We expect to continue to employ a three-pronged distribution strategy 
using systems integrators, OEMs, and direct sales. 

Our strategy for growing our biometrics business may include one or more of the following elements: 

10

i)

Product strategy – Our product strategy is to offer more complete biometrics solutions. We believe this 
strategy will allow us to us to sell more software and services into biometrics projects. We recognized the 
need to make this transition several years ago and began developing products to enable this strategy. 

Our strategy to offer complete solutions involves:  

(cid:120)

(cid:120)

Product  line  expansion  -  Our  aim  is  to  expand  our  product  portfolio  by  adding  new  products  and 
increasing the functionality of existing products using our internal engineering teams.  This means 
we may add resources to our engineering staff.  To the extent we are unable to develop critical new 
technologies  internally,  we  may  purchase  or  license  such  technologies  from  third  parties. 
Alternatively, we may also acquire biometrics companies provided we believe the acquisition cost is 
reasonable relative to the estimated future revenue and profits the acquired company may produce. 

Engineering  services  –  We  believe  that  services  are  an  important  element  of  our  strategy  to  sell 
complete solutions. We intend to have adequate engineering resources on hand to ensure that we can 
staff projects with the technical expertise we need to win new projects. 

ii)

Market  strategy  –  Our  market  strategy  is  to  continue  to  focus  on  our  legacy  government  biometrics 
market and expand into new commercial biometrics markets. Historically our revenue has been primarily 
derived from the government biometrics market and we intend to continue our focus there. 

We  believe  the  evolution  of  commercial  markets  over  the  past  year  may  present  opportunities  to  us.  
While  it  is  unlikely  that  we  will  pursue  opportunities  in  the  mobile  segment  of  the  market,  we  are 
beginning  see  opportunities  in  the  enterprise  segment.    The  requirements  of  the  enterprise  segment 
appear to be well suited to our technology, products, and expertise.   

iii)

Sales strategy – While the United States remains a large market, we believe there are attractive growth 
opportunities  in  international  markets.  We  intend  to  continue  our  focus  on  international  markets  and 
pursue opportunities there through additions to our sales staff, as well as through the use of third party 
sales agents.  

As  we  attempt  to  grow  our  biometrics  business,  we  may  make  investments  in  growth  initiatives,  such  as  those 
described above, that may cause our profitability to decline in the near term. 

Our  strategy  does  not  include  growing  biometrics  hardware  revenue.    Hardware  revenue  in  2014  and  2013 
represents  an  accommodation  to  an  important  customer.    It  is  unlikely  that  we  will  have  meaningful  sales  of 
hardware in future periods as this customer appears to have completed the bulk of its purchasing.  

Backlog 

We had $5.0 million of backlog on December 31, 2014. Backlog included: i) $3.2 million of software license and 
service  revenue  that was  scheduled for delivery  in  the first  nine  months  of 2015;  and ii)  $1.8  million of  software 
maintenance revenue that will be recognized from deferred revenue during 2015. There was no hardware revenue or 
royalties included in backlog at December 31, 2014. 

Research and Development

Our  research  and  development  activities  are  focused  on  enhancing  our  existing  products  and  developing  new 
products.  Our engineering organization is based in Bedford, Massachusetts.  As of December 31, 2014, we had an 
engineering staff of 48 employees, representing 69% of our total employee staff. 

During  the  years  ended  December  31,  2014,  2013,  and  2012,  research  and  development  expenses  totaled  $5.5 
million, $4.1 million, and $3.5 million, respectively.  We expect that we will continue to invest substantial funds in 
research and development activities.   

11

Patents and Intellectual Property  

We  rely  on  a  combination  of  nondisclosure  agreements  and  other  contractual  provisions,  as  well  as  patent, 
trademark, trade secret and copyright law to protect our proprietary rights.  We have an active program to protect 
our proprietary technology through the filing of patents.  As of December 31, 2014, we had approximately 40 U.S. 
and foreign patents and approximately 49 pending patent applications.  Our patents and patent applications pertain 
primarily to biometrics and imaging compression. 

Although  we  have  patented  certain  aspects  of  our  technology,  we  rely  primarily  on  trade  secrets  to  protect  our 
intellectual property.  We attempt to protect our trade secrets and other proprietary information through agreements 
with our customers, suppliers, employees and consultants, and through security measures.  Each of our employees is 
required  to  sign  a  non-disclosure  and  non-competition  agreement.    Although  we  intend  to  protect  our  rights 
vigorously, we cannot assure you that these measures will be successful.  In addition, effective intellectual property 
protection may be unavailable or limited in certain foreign countries.  

Third  parties  may  assert  exclusive  patent,  copyright  and  other  intellectual  property  rights  to  technologies  that  are 
important to us.  From time  to time, we receive claims from third parties suggesting that we may be obligated to 
license such intellectual property rights.  If we were found to have infringed any third party’s patents, we could be 
subject to substantial damages or an injunction preventing us from conducting our business. 

Manufacturing & Systems Integration 

We do not design or manufacture hardware products, however we provide systems integration services for one U.S. 
government customer.  Our systems integration activities include: i) procuring hardware and software components 
from third party suppliers; ii) installing Aware and third party software on the purchased hardware; and iii) testing 
products for quality assurance prior to shipment. 

We rely on single source suppliers for certain critical hardware and software components. Our dependence on single 
source suppliers involves several risks, including limited control over availability, quality, and delivery schedules. 
Any delays in delivery or shortages of such components could cause delays in the shipment of our products, which 
could harm our business.   

Employees 

At December 31, 2014, we employed 70 people, including 48 in engineering, 11 in sales and marketing, and 11 in 
finance  and  administration.    Of  these  employees,  67  were  based  in  Massachusetts.    None  of  our  employees  are 
represented by a labor union.  We consider our employee relations to be good.  

We  believe  that  our  future  success  will  depend  in  large  part  on  the  service  of our  technical,  sales, marketing  and 
senior  management  personnel  and  upon  our  ability  to  retain  highly  qualified  technical,  sales  and  marketing  and 
managerial personnel.  We cannot assure you that we will be able to retain our key managers and employees or that 
we will be able to attract and retain additional highly qualified personnel in the future. 

DSL Discontinued Operations 

From  the  early  1990s until  2013, we were engaged  in  the  Digital  Subscriber Line (“DSL”)  industry. We  sold  the 
assets of our DSL semiconductor intellectual property business in 2009, and shut down our DSL service assurance 
hardware and software businesses in 2012 and 2013, respectively. Results from the shutdown of our DSL service 
assurance businesses were reported in discontinued operations in the years ended December 31, 2013 and 2012. 

Notwithstanding the sale of DSL semiconductor intellectual property assets in 2009, we continue to receive royalty 
payments from two customers.  DSL royalties are reported in continuing operations in accordance with ASC 205-20, 
Reporting Discontinued Operations, because we have continuing cash flows from this business.  DSL royalties have 
been declining in recent years and represented approximately 3% of total revenue in 2014.  We expect royalties will 
continue to decline in future periods. 

12

Segment Information; Financial Information About Geographic Areas 

We  organize  ourselves  into  a  single  segment  that  reports  to  the  chief  operating  decision  makers.    Summaries  of 
revenue by geographic regions and revenue by product group are set forth in Note 10 to our consolidated financial 
statements included elsewhere in this Annual Report.

Available Information 

Our  Annual  Report  on  Form  10-K,  Quarterly  Reports  on  Form  10-Q,  Current  Reports  on  Form  8-K,  proxy 
statements, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 
1934,  as  amended,  are  made  available  free  of  charge  on  or  through  our  website  at  www.aware.com  as  soon  as 
reasonably  practicable  after  such reports  are  filed  with,  or  furnished  to,  the  Securities  and  Exchange  Commission 
(the SEC). The SEC also maintains a website, www.sec.gov, that contains reports and other information regarding 
issuers  that  file  electronically  with  the  SEC.    Such  reports,  proxy  statements,  and  other  information  may  also  be 
obtained by visiting  the  Public  Reference Room  of  the  SEC  at  100  F  Street,  N.E., Washington,  DC,  20549 or by 
calling the SEC at 1-800-SEC-0330. 

Copies of our (i) Corporate Governance Principles, (ii) charters for the Audit Committee, Compensation Committee, 
and Nominating Committee, and (iii) Code of Ethics are available in the Investor Relations section of our website at 
www.aware.com.

13

ITEM 1A.  RISK FACTORS

Our operating results may fluctuate significantly from period-to-period and are difficult to predict. 

Individual orders can represent a meaningful percentage of our revenues and net income in any single quarter and 
the  timing  of  the  receipt  of  those  orders  is  difficult  to  predict.  The  failure  to  close  an  order  or  the  deferral  or 
cancellation of  an order  can result  in  revenue  and net  income  shortfalls  for  that quarter. We base  our  current  and 
future expense levels on our internal operating plans and sales forecasts, and our operating costs are to a large extent 
fixed. As a result, we may not be able to sufficiently reduce our costs in any quarter to adequately compensate for an 
unexpected near-term shortfall in revenues, and even a small shortfall could disproportionately and adversely affect 
financial results for that quarter.  

Our financial results may be negatively affected by a number of factors, including the following:  

•

•
•
•
•
•
•
•
•
•

the  lack  or  reduction  of  government  funding  and  the  political,  budgetary  and  purchasing  constraints  of 
government customers who purchase products and services directly or indirectly from us;  
the terms of customer contracts that affect the timing of revenue recognition;  
the size and timing of our receipt of customer orders;  
significant fluctuations in demand for our products and services;  
the loss of a key customer or one of its key customers; 
new competitors, or the introduction of enhanced solutions from new or existing competitors;  
competitive pressures on selling prices; 
cancellations, delays or contract amendments by government customers; 
higher than expected costs, asset write-offs, and other one-time financial charges; and 
general economic trends and other factors 

As a result of these factors, we believe that period-to-period comparisons of our revenue levels and operating results 
are not necessarily meaningful.  You should not rely on our quarterly revenue and operating results to predict our 
future performance. 

We  derive  a  significant  portion  of  our  revenue  directly  or  indirectly  from  government  customers,  and  our 
business may be adversely affected by changes in the contracting or fiscal policies of those governmental entities.  

We  derive  a  significant  portion  of  our  revenue  directly  or  indirectly  from  federal,  international,  state  and  local 
governments.  We  believe  that  the  success  and  growth  of  our  business  will  continue  to  depend  on  government 
customers purchasing our products and services either directly through us or indirectly through our channel partners. 
Changes in government contracting policies or government budgetary constraints may adversely affect our financial 
performance. Among the factors that could adversely affect our business are:  

•
•
•
•
•
•
•
•

changes in fiscal policies or decreases in available government funding,  
changes in government funding priorities;  
changes in government programs or applicable requirements;  
the adoption of new laws or regulations or changes to existing laws or regulations;  
changes in political or social attitudes with respect to security and defense issues;  
changes in audit policies and procedures of government entities;  
potential delays or changes in the government appropriations process; and  
delays in the payment of our invoices by government payment offices.  

These and other factors could cause government customers or our channel partners to reduce purchases of products 
and services from us which would have a material adverse effect on our business, financial condition and operating 
results. 

14

A significant commercial market for biometrics technology may not develop, and, even if it does, there can be no 
assurance our biometrics technology will be successful.  

A  component  of  our  strategy  to  grow  revenue  includes  expansion  into  commercial  markets.  To  date,  biometrics 
technology  has  received  only  limited  acceptance  in  such  markets.      Although  the  recent  appearance  of  biometric 
readers  on  popular  consumer  products,  such  as  smartphones,  has  increased  interest  in  biometrics  as  a  means  of 
authenticating  and/or  identifying  individuals,  commercial  markets  for  biometrics  technology  are  in  the  process  of 
developing  and  evolving.      Biometrics-based  solutions  compete  with  more  traditional  security  methods  including 
keys,  cards,  personal  identification  numbers  and security  personnel. Acceptance of biometrics  as  an  alternative  to 
such traditional methods depends upon a number of factors including: i) the performance and reliability of biometric 
solutions; ii) costs involved in adopting and integrating biometric solutions; iii) public concerns regarding privacy; 
and iv) potential privacy legislation. 

For  these  reasons,  we  are  uncertain  whether  there  will  be  significant  demand  for  biometrics  technology  from 
commercial markets. Moreover, even if there is significant demand, there can be no assurance that our biometrics 
products will achieve market acceptance.

We derive a significant portion of our revenue from third party channel partners.

Our future results depend upon the continued successful distribution of our products through a channel of systems 
integrators and OEM partners. Systems integrators, including value added resellers, use our software products as a 
component of the biometrics systems they deliver to their customers. OEMs embed our software products in their 
technology  devices  or  software  products.  These  channel  partners  typically  sell  their  products  and  services  to 
government customers.  

Our  failure  to  effectively  manage  our  relationships  with  these  third  parties  could  impair  the  success  of  our  sales, 
marketing and support activities. Moreover, the activities of these third parties are not within our direct control. The 
occurrence of any of the following events could have a material adverse effect on our business, financial condition 
and operating results: 

(cid:120) a reduction in sales efforts by our partners; 
(cid:120) the failure of our partners to win government awards in which our products are used; 
(cid:120) a reduction in technical capabilities or financial viability of our partners; 
(cid:120) a misalignment of interest between us and them; 
(cid:120) the termination of our relationship with a major systems integrator or OEM; or 
(cid:120) any adverse effect on a partner’s business related to competition, pricing and other factors. 

If  the  biometrics  market  does  not  experience  significant  growth  or  if  our  products  do  not  achieve  broad 
acceptance both domestically and internationally, we may not be able to grow our business. 

Our revenues are derived primarily from sales of biometrics products and services. We cannot accurately predict the 
future growth rate or the size of the biometrics market. The expansion of the biometrics market and the market for 
our biometrics products and services depend on a number of factors, such as:  

•

•

•
•

the cost, performance and reliability of our products and services and the products and services offered by 
our competitors; 
the  continued  growth  in  demand  for  biometrics  solutions  within  the  government  and  law  enforcement 
markets  as  well  as  the  development  and  growth  of  demand  for  biometric  solutions  in  markets  outside  of 
government and law enforcement; 
customers’ perceptions regarding the benefits of biometrics solutions;  
public perceptions regarding the intrusiveness of these solutions and the manner in which organizations use 
the biometric information collected;  
public perceptions regarding the confidentiality of private information;  
proposed or enacted legislation related to privacy of information;  
customers’ satisfaction with biometrics solutions; and  

•
•
•
• marketing efforts and publicity regarding biometrics solutions. 

15

Even  if  biometrics  solutions  gain  wide  market  acceptance,  our  solutions  may  not  adequately  address  market 
requirements  and  may  not  continue  to  gain  market  acceptance.  If  biometrics  solutions  generally  or  our  solutions 
specifically do not gain wide market acceptance, we may not be able to achieve our anticipated level of growth and 
our revenues and results of operations would be adversely affected. 

Hardware revenue is likely to decline in future periods.  

In  the  years  ended  December  31,  2014  and  2013,  we  had  hardware  revenue  of  $4.9  million  and  $3.2  million 
respectively.  Gross profit on hardware revenue was $1.4 million and $0.8 million in 2014 and 2013, respectively. 

Hardware revenue consisted of sales of biometrics equipment to a single U.S. government customer.  While we are 
unable  to  predict  future  hardware  sales  with  any  degree  of  certainty,  future  orders  from  this  customer  may  be 
minimal as we believe that the bulk of its purchases may have already occurred.  We have no hardware orders in 
backlog as of December 31, 2014.  If we are unable to replace the lost gross profit on hardware revenue with sales of 
other products and services in future periods, our operating results will be adversely affected. 

We face intense competition from other biometrics solutions providers. 

A  significant  number  of  established  companies  have  developed  or  are  developing  and  marketing  software  and 
hardware  for  biometrics  products  and  applications  that  currently  compete  with  or  will  compete  directly  with  our 
offerings.  We believe that additional competitors will enter the biometrics market and become significant long-term 
competitors, and that, as a result, competition will increase.  Companies competing with us may introduce solutions 
that are competitively priced, have increased performance or functionality or incorporate technological advances we 
have not yet developed or implemented. Our current principal competitors include:  

•

•

Diversified technology providers that offer integrated biometrics solutions to governments, law enforcement 
agencies  and  other  organizations.    This  group  of  competitors  includes  companies  such  as  Safran  Morpho, 
3M/Cogent, and NEC. 

Component  providers  that  offer  biometrics  software  and  hardware  components  for  fingerprint,  facial,  and 
  This  group  of  competitors  includes  companies  such  as  Cognitec; 
iris  biometric  identification. 
Neurotechnology; Iritech; Innovatrics; WCC; Daon; and M2Sys.  

We  expect  competition  to  intensify  in  the  near  term  in  the  biometrics  market.  Many  current  and  potential 
competitors  have  substantially  greater  financial,  marketing,  and  research  resources  than  we  have.    Moreover,  low 
cost foreign competitors from third world and other countries have demonstrated a willingness to sell their products 
at significantly reduced prices. To compete effectively in this environment, we must continually develop and market 
new and enhanced solutions and technologies at competitive prices and must have the resources available to invest 
in significant research and development activities. Our failure to compete successfully could cause our revenues and 
market share to decline.  

The biometrics industry is characterized by rapid technological change and evolving industry standards, which 
could render our existing products obsolete.  

Our  future  success  will  depend  upon  our  ability  to  develop  and  introduce  a  variety  of  new  capabilities  and 
enhancements to our existing products in order to address the changing and sophisticated needs of the marketplace. 
Frequently, technical development programs in the biometrics industry require assessments to be made of the future 
direction  of  technology,  which  is  inherently  difficult  to  predict.  Delays  in  introducing  new  products  and 
enhancements, the failure to choose correctly among technical alternatives or the failure to offer innovative products 
or enhancements at competitive prices may cause customers to forego purchases of our products and purchase our 
competitors’ products. We may not have adequate resources available to us or may not adequately keep pace with 
appropriate requirements in order to effectively compete in the marketplace. 

16

Our software products may have errors, defects or bugs, which could result in delayed or lost revenue, expensive 
correction, liability to our customers, and claims against us.  

Complex  software  products  such  as  ours  may  contain  errors,  defects  or  bugs.  Defects  in  the  products  that  we 
develop and sell to our customers could require expensive corrections and result in delayed or lost revenue, adverse 
customer reaction and negative publicity about us or our products and services. Customers who are not satisfied with 
any  of  our  products  may  also  bring  claims  against  us  for  damages,  which,  even  if  unsuccessful,  would  likely  be 
time-consuming to defend, and could result in costly litigation and payment of damages. Such claims could harm 
our reputation, financial results and competitive position. 

Our business may be adversely affected by our use of open source software.  

The software industry is making increasing use of open source software in the development of products. We also 
license  and  integrate  certain  open  source  software  components  from  third  parties  into  our  software.  Open  source 
software license agreements may require that the software code in these components or the software into which they 
are integrated be freely accessible under open source terms. Many features we may wish to add to our products in 
the  future  may  be  available  as  open  source  software  and  our  development  team  may  wish  to  make  use  of  this 
software to reduce development costs and speed up the development process. While we carefully monitor the use of 
all open source software and try to ensure that no open source software is used in such a way as to require us to 
disclose the source code to the related product, such use could inadvertently occur.  If we were required to make our 
software freely available, our business could be seriously harmed. 

Our intellectual property is subject to limited protection. 

Because  we  are  a  technology  provider,  our  ability  to  protect  our  intellectual  property  and  to  operate  without 
infringing  the  intellectual  property  rights  of  others  is  critical  to  our  success.    We  regard  our  technology  as 
proprietary.    We  rely  on  a  combination  of  patent,  trade  secret,  copyright,  and  trademark  law  as  well  as 
confidentiality  agreements  to  protect  our  proprietary  technology,  and  cannot  assure  you  that  we  will  be  able  to 
enforce  the  patents  we  own  against  third  parties.  Despite  our  efforts,  these  measures  can  only  provide  limited 
protection.  Unauthorized  third  parties  may  try  to  copy  or  reverse  engineer  portions  of  our  products  or  otherwise 
obtain  and  use  our  intellectual  property.  If  we  fail  to  protect  our  intellectual  property  rights  adequately,  our 
competitors may gain access to our technology, and our business would thus be harmed.  

In the future, we may be involved in legal action to enforce our intellectual property rights relating to our patents, 
copyrights  or  trade  secrets.    Any  such  litigation  could  be  costly  and  time-consuming  for  us,  even  if  we  were  to 
prevail.    Moreover,  even  if  we  are  successful  in  protecting  our  proprietary  information,  our  competitors  may 
independently develop technologies substantially equivalent or superior to our technology.  Accordingly, despite our 
efforts, we may be unable to prevent third parties from infringing upon or misappropriating our intellectual property 
or  otherwise  gaining  access  to  our  technology.    The  misappropriation  of  our  technology  or  the  development  of 
competitive technology could seriously harm our business. 

We may be sued by third parties for alleged infringement of their proprietary rights.

Our technology and products may infringe the intellectual property rights of others.  A large and increasing number 
of participants in the technology industry, including companies known as non-practicing entities, have applied for or 
obtained  patents.  Some  of  these  patent  holders  have  demonstrated  a  readiness  to  commence  litigation  based  on 
allegations of patent infringement.  Third parties have asserted against us in the past and may assert against us in the 
future patent, copyright and other intellectual property rights to technologies that are important to our business.   

Intellectual property rights can be uncertain and involve complex legal and factual questions.  Moreover, intellectual 
property claims, with or without merit, can be time-consuming and expensive to litigate or settle, and could divert 
management  attention  away  from  the  execution  of  our  business  plan.    If  we  were  found  to  have  infringed  the 
proprietary  rights  of  others,  we  could  be  subject  to  substantial  damages  or  an  injunction  preventing  us  from 
conducting our business.  

17

If we are unable to attract and retain key personnel, our business could be harmed.  
If any of our key employees were to leave, we could face substantial difficulty in hiring qualified successors and 
could  experience  a  loss  in  productivity  while  any  successor  obtains  the  necessary  training  and  experience.  Our 
employment relationships are at-will and we have had key employees leave in the past. We cannot assure you that 
one or more key employees will not leave in the future. We  intend to continue to hire additional highly qualified 
personnel,  including  software  engineers  and  sales  personnel,  but  may  not  be  able  to  attract,  assimilate  or  retain 
qualified personnel in the future. Any failure to attract, integrate, motivate and retain these employees could harm 
our business. 

We rely on single sources of supply for certain components used in our hardware products. 

We commenced sales of biometrics hardware products to a U.S. government customer in 2013. Hardware products 
sold  to  this  customer  integrate  hardware  and  software  purchased  from  third  parties.  We  rely  on  single  source 
suppliers for certain critical hardware and software components. Our dependence on single source suppliers involves 
several risks, including limited control over availability, quality, and delivery schedules. Any delays in delivery or 
shortages of such components could cause delays in the shipment of our products, which could harm our business.   

Our business may be affected by government regulations. 

Extensive  regulation  by  federal,  state,  and  foreign  regulatory  agencies  could  adversely  affect  us  in  ways  that  are 
difficult for us to predict. In addition, our business may also be adversely affected by: i) the imposition of tariffs, 
duties and other import restrictions on goods and services we purchase from non-domestic suppliers; or ii) by the 
imposition  of  export  restrictions  on  products  we  sell  internationally.  Changes  in  current  or  future  laws  or 
regulations, in the United States or elsewhere, could seriously harm our business. 

Adverse economic conditions could harm our business. 

Unfavorable changes in economic conditions, including recessions, inflation, turmoil in financial markets, or other 
changes in economic conditions, could harm our business, results of operations, and financial conditions as a result 
of: 

(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)

reduced demand for our products;  
increased risk of order cancellations or delays; 
increased pressure on the prices for our products;  
greater difficulty in collecting accounts receivable; and 
risks to our liquidity, including the possibility that we might not have access to our cash when needed.  

We are unable to predict the timing, duration, and severity of any such adverse economic conditions in the U.S. and 
other countries, but the longer the duration, the greater the risks we face in operating our business. 

We may make acquisitions of companies. 

We  may  make  acquisitions  of  companies  that  offer  complementary  products,  services  and  technologies.  Any 
acquisitions  we  may  complete  involve  a  number  of  risks,  including  the  risks  of  assimilating  the  operations  and 
personnel of acquired companies, realizing the value of the acquired assets relative to the price paid, distraction of 
management from our ongoing businesses and potential product disruptions associated with the sale of the acquired 
company’s  products.  These  factors  could  have  a  material  adverse  effect  on  our  business,  financial  condition, 
operating results and cash flows. The consideration we pay for any future acquisitions could include our stock. As a 
result, future acquisitions could cause dilution to existing shareholders and to earnings per share. 

We may have additional tax liabilities.

We  are  subject  to  income  taxes  in  the  United  States.  Significant  judgments  are  required  in  determining  our 
provisions for income taxes. In the course of preparing our tax provisions and returns, we must make calculations 
where the ultimate tax determination may be uncertain. Our tax returns are subject to examination by the Internal 

18

Revenue Service (“IRS”) and state tax authorities. The IRS is currently examining our tax return for the year ended 
December  31,  2012.  There  can  be  no  assurance  as  to  the  outcome  of  these  examinations.  If  the  ultimate 
determination of taxes owed is for an amount in excess of amounts previously accrued, our operating results, cash 
flows, and financial condition could be adversely affected.  

The market price of our common stock has been and may continue to be subject to wide fluctuations, and this 
may make it difficult for shareholders to resell the common stock when they want or at prices they find attractive.  

The market price of our common stock, like that of other technology companies, is volatile and is subject to wide 
fluctuations in response to a variety of factors, including: 

(cid:120)
(cid:120)
(cid:120)
(cid:120)
(cid:120)

(cid:120)

quarterly variations in operating results; 
announcements of technological innovations or new products by us or our competitors,  
changes in customer relationships, such as the loss of a key customer; 
recruitment or departure of key personnel; 
corporate actions we may initiate, such as acquisitions, stock sales or repurchases, dividend declarations, or 
corporate reorganizations; and 
other events or factors.  

Our stock price may also be affected by broader market trends unrelated to our performance. As a result, purchasers 
of our common stock may be unable at any given time to sell their shares at or above the price they paid for them. 
Moreover, companies that have experienced volatility in the market price of their stock often are subject to securities 
class  action  litigation.  If  we  were  the  subject  of  such  litigation,  it  could  result  in  substantial  costs  and  divert 
management's attention and resources. 

If we are unable to maintain effective internal controls over financial reporting, investors could lose confidence 
in the reliability of our financial statements, which could result in a decline in the price of our common stock. 

As a public company, we are required to enhance and test our financial, internal and management control systems to 
meet obligations imposed by the Sarbanes-Oxley Act of 2002. Consistent with the Sarbanes-Oxley Act and the rules 
and regulations of the SEC, management's assessment of our internal controls over financial reporting and the audit 
opinion  of  our  independent  registered  accounting  firm  as  to  the  effectiveness  of  our  controls  is  required  in 
connection  with  our  filing  of  our  Annual  Report  on  Form  10-K.  If  we  are  unable  to  identify,  implement  and 
conclude that we have effective internal controls over financial reporting or if our independent auditors are unable to 
conclude  that  our  internal  controls  over  financial  reporting  are  effective,  investors  could  lose  confidence  in  the 
reliability  of  our  financial  statements,  which  could  result  in  a  decrease  in  the  value  of  our  common  stock.  Our 
assessment of our internal controls over financial reporting may also uncover weaknesses or other issues with these 
controls that could also result in adverse investor reaction. 

We must make judgments in the process of preparing our financial statements. 

We prepare our financial statements in accordance with generally accepted accounting principles and certain critical 
accounting policies that are relevant to our business.  The application of these principles and policies requires us to 
make significant judgments and estimates.  In the event that our judgments and estimates differ from actual results, 
we may have to change them, which could materially affect our financial position and results of operations. 

Moreover,  accounting  standards  have  been  subject  to  rapid  change  and  evolving  interpretations  by  accounting 
standards setting organizations over the past few years.  The implementation of new accounting standards requires 
us  to  interpret  and  apply  them  appropriately.    If  our  current  interpretations  or  applications  are  later  found  to  be 
incorrect, we may have to restate our financial statements and the price of our stock could decline.  

19

ITEM 1B. UNRESOLVED STAFF COMMENTS 

Not applicable.  

ITEM 2.   PROPERTIES

We believe that our existing facilities are adequate for our current needs and that additional space sufficient to meet 
our  needs  for  the  foreseeable  future  will  be  available  on  reasonable  terms.    We  currently  occupy  approximately 
72,000 square feet of office space in Bedford, Massachusetts, which serves as our headquarters.  This site is used for 
our research and development, sales and marketing, and administrative activities.  We own this facility.  

ITEM 3.   LEGAL PROCEEDINGS

From time to time we are involved in litigation incidental to the conduct of our business.  We are not party to any 
lawsuit or proceeding that, in our opinion, is likely to seriously harm our business. 

ITEM 4.   MINE SAFETY DISCLOSURES  

Not applicable. 

20

PART II 

ITEM 5.  MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS 
AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stock is the only class of stock we have outstanding, and it trades on the Nasdaq Global Market under 
the  symbol  AWRE.    The  following  table  sets  forth  the  high  and  the  low  sales  prices  of  our  common  stock  as 
reported on the Nasdaq Global Market for the periods indicated from January 1, 2013 to December 31, 2014. 

2014 
   High ..................................  
   Low ..................................  

2013 
   High ..................................  
   Low ..................................  

First 
Quarter 

Second 
Quarter 

Third 
Quarter 

Fourth 
Quarter 

$6.70 
5.27 

$6.25 
4.58 

$6.70 
5.02 

$5.65 
4.50 

$6.79 
3.50 

$5.64 
4.80 

$5.02 
3.46 

$6.14 
5.06 

As  of  February  5,  2015,  we  had  approximately  106  shareholders  of  record.    This  number  does  not  include 
shareholders  from  whom  shares  were  held  in  a  “nominee”  or  “street”  name.    In  2014,  we  paid  a  special  cash 
dividend  of  $1.75  per  share  on  July  24,  2014.    We  paid  no  dividends  in  2013.    In  2012,  we  paid  a  special  cash 
dividend of $1.15 per share on May 25, 2012 and another special cash dividend of $1.80 per share on December 17, 
2012.  We anticipate that we will continue to reinvest any earnings to finance future operations although we may 
also pay additional special cash dividends if our board of directors deems it appropriate. 

We  did  not  sell  any  equity  securities  that  were  not  registered  under  the  Securities  Act  of  1933  during  the  three 
months ended December 31, 2014. 

21

 
 
Stock Performance Graph 

The following stock performance graph compares the performance of Aware’s cumulative stockholder return with 
that of a broad market index, the Nasdaq Composite Index, and a published industry index, the RDG Technology 
Composite Index.  The cumulative stockholder returns for shares of Aware’s common stock and for the market and 
industry  indices  are  calculated  assuming  $100  was  invested  on  December  31,  2009.    Aware  paid  special  cash 
dividends of $0.00, $0.00, $2.95, $0.00, and $1.75 per share in 2010, 2011, 2012, 2013, and 2014, respectively.  The 
performance of the market and industry indices is shown on a total return, or dividend reinvested, basis.  

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among Aware, Inc., the NASDAQ Composite Index, and the RDG Technology Composite Index

$400

$350

$300

$250

$200

$150

$100

$50

$0

12/09

12/10

12/11

12/12

12/13

12/14

Aware, Inc.

NASDAQ Composite

RDG Technology Composite

*$100 invested on 12/31/09 in stock or index, including reinvestment of dividends.
Fiscal year ending December 31.

Aware, Inc. .................................................. 
Nasdaq Composite Index. ............................ 
RDG Technology Composite Index ............ 

Value of Investment ($)
12/31/09 12/31/10  12/31/11 12/31/12 12/31/13  12/31/14
$101.43 $107.14 $312.06 $347.94  $349.02
$100.00
223.74
139.00
117.61
100.00
193.22
126.07
111.01
100.00

118.70
110.85

196.83
167.16

22

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 6.  SELECTED FINANCIAL DATA

The  following  selected  consolidated  financial  and  operating  data  set  forth  below  with  respect  to  our  consolidated 
financial statements for the fiscal years ended December 31, 2014, 2013 and 2012 are derived from the consolidated 
financial statements included elsewhere in this Form 10-K. The data for fiscal years ended December 31, 2011 and 
2010 are derived from previously filed consolidated financial statements.  The data set forth below should be read in 
conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” our 
historical consolidated financial statements, and the related notes to the consolidated financial statements, which can 
be found in Item 7 and Item 8.  

2010 

$12,975 
- 
(360) 
154 

26 
180 
$0.01 
$0.01 

$39,949 
43,818 
53,400 
3,517 
49,883 

Year ended December 31,  

2014 

2013 

2012 
(in thousands, except per share data) 

2011 

Statements of Comprehensive Income Data
Revenue ........................................................  
Patent related income .....................................
Operating income (loss) .................................
Income from continuing operations ...............
Income (loss) from discontinued operations, 
net of income taxes ....................................
Net income .....................................................
Net income per share – basic .........................
Net income per share – diluted ......................

Balance Sheet Data 
Cash and cash equivalents ............................  
Working capital ............................................  
Total assets ....................................................  
Total liabilities ..............................................  
Total stockholders’ equity ............................  

$23,720 
2,127 
7,089 
4,583 

-
4,583
$0.20
$0.20

$43,985
44,745
55,893 
3,504 
52,389 

$19,357 
780 
5,318 
3,752 

(1,156) 
2,596
$0.12
$0.11

$17,304 
87,515 
92,558 
72,383 

(76) 
72,307
$3.32
$3.28

$72,660
75,760
89,329 
4,179 
85,150 

$71,074
73,358
85,854
3,958
81,896

$16,199 
- 
3,500 
3,581 

(1,014) 
2,567 
$0.12 
$0.12 

$46,577 
48,069 
57,851 
3,276 
54,575 

23

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 7.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
RESULTS OF OPERATIONS

RESULTS OF OPERATIONS 

The following table sets forth, for the years indicated, certain line items from our consolidated statements of income 
and comprehensive income stated as a percentage of total revenue: 

Revenue: 
   Software licenses ..............................................................................  
   Software maintenance .......................................................................  
   Services.............................................................................................  
   Hardware ..........................................................................................  
   Royalties ...........................................................................................  
     Total revenue ..................................................................................  

Costs and expenses: 
   Cost of hardware ...............................................................................  
   Cost of services .................................................................................  
   Research and development ...............................................................  
   Selling and marketing .......................................................................  
   General and administrative ...............................................................  
      Total costs and expenses ................................................................  

Patent related income ...........................................................................  

Operating income  ...............................................................................  
Other income (expense) .......................................................................  
Interest income ....................................................................................  
Income from continuing operations before income taxes ....................  
Provision for income taxes ..................................................................  
Income from continuing operations  ....................................................  
Loss from discontinued operations, net of income taxes ...................... 
Net income  ........................................................................................... 

Year ended December 31, 
2013 

2012 

2014 

36% 
18 
22  
21  
3 
100 

15 
10 
23 
16 
15 
79 

9 

30 
- 
- 
30 
11 
19 
- 
19% 

43% 
20 
16  
16  
5 
100 

12 
8 
21 
18 
18 
77 

4 

27 
- 
2 
29 
10 
19 
(6) 
13% 

55% 
18 
15  
-  
12 
100 

- 
9 
20 
20 
22 
71 

506 

535 
- 
1 
536 
118 
418 
- 
418% 

Summary of Operations  

Continuing Operations. We are primarily engaged in the development and sale of biometrics products and services.  
Our  software  products  are  used  in  government  and  commercial  biometrics  systems  to  identify  or  authenticate 
people. Principal government applications of biometrics systems include border control, law enforcement, national 
defense, secure credentialing, access control, and background checks. Principal commercial applications include: i) 
user  authentication  for  login  and  access  to  mobile  devices,  computers,  networks,  and  software  programs;  ii)  user 
authentication  for  financial  transactions  and  purchases  (online  and  in-person);  iii)  physical  access  control  to 
buildings, and iv) screening and background checks of prospective employees and customers. We sell our software 
and services globally through systems integrators and OEMs, and directly to end user customers.  We also derive a 
minor portion of our revenue from the sale of imaging software to OEMs that incorporate that software into medical 
imaging products. 

Discontinued  Operations. We  shut  down  our  DSL  service  assurance  hardware  product  line  in  2012  and  our  DSL 
service  assurance  software  product  line  in  2013.  Both  of  these  product  lines  were  previously  components  of  our 
DSL  Service  Assurance  Segment.  The  results  of  the  DSL  Service  Assurance  Segment  have  been  reported  as 
discontinued operations as we no longer have any significant continuing involvement with, or cash flows from, this 
segment. 

24

 
 
 
Summary of Financial Results

Income  from  continuing operations for  the year  ended December 31, 2014  was $4.6  million, or $0.20 per  diluted 
share, which compares to income from continuing operations of $3.8 million, or $0.16 per diluted share, for the year 
ended December 31, 2013.  Higher income from continuing operations in 2014 was primarily due to an increase in 
patent related income.  

Income  from  continuing operations for  the year  ended December 31, 2013  was $3.8  million, or $0.16 per  diluted 
share, which compares to income from continuing operations of $72.4 million, or $3.28 per diluted share, for the 
year ended December 31, 2012.  Lower income from continuing operations in 2013 was primarily due to a decrease 
in patent related income.  

Software Licenses 

Software licenses consist of revenue from the sale of biometrics and imaging software products. Sales of software 
products depend on our ability to win proposals to supply software for biometrics systems projects either directly to 
end user customers or indirectly through channel partners. 

Software license revenue increased 4% from $8.2 million in 2013 to $8.5 million in 2014.  As a percentage of total 
revenue,  software  license  revenue  decreased  from  43%  in  2013  to  36%  in  2014.    The  dollar  increase  in  software 
license  revenue  was  primarily  due  to  a  $0.4  million  increase  in  sales  of  imaging  software.  Sales  of  biometrics 
software licenses were essentially unchanged from 2013, which reflects approximately the same number of project 
wins in both years. 

Software license revenue decreased 13% from $9.5 million in 2012 to $8.2 million in 2013.  As a percentage of total 
revenue, software license revenue decreased from 55% in 2012 to 43% in 2013.  The dollar decrease in software 
license revenue was primarily due to lower sales to systems integrator and OEM customers.  Software license sales 
to direct government customers were approximately the same in both years. We believe that lower software demand 
from  channel  partners  in  2013  was  primarily  attributable  to  two  factors:  i)  our  partners  won  fewer  new  systems 
projects proposals involving our software in 2013; and ii) some larger projects that commenced in 2011 and 2012 
wound down during 2013. 

Software Maintenance 

Software maintenance consists of revenue from the sale of software maintenance contracts. Software maintenance 
contracts  entitle  customers  to  receive  software  support  and  software  updates,  if  and  when  they  become  available, 
during the term of the contract. 

Software maintenance revenue increased 13% from $3.9 million in 2013 to $4.4 million in 2014.  As a percentage of 
total revenue, software maintenance revenue decreased from 20% in 2013 to 18% in 2014.   

Software maintenance revenue increased 27% from $3.0 million in 2012 to $3.9 million in 2013. As a percentage of 
total revenue, software maintenance revenue increased from 18% in 2012 to 20% in 2013.   

The  dollar  increase  in  software  maintenance  revenue  in  2014  and  2013  was  primarily  due  to  a  growing  base  of 
customers who use our software and who also purchase maintenance contracts on that software.  A majority of our 
customers  purchase  software  maintenance  contracts  when  they  initially  purchase  software  licenses.    Since  our 
software is used in active biometrics systems, many of our customers continue to renew their maintenance contracts 
in subsequent years while systems remain operational.  

Services

Services  consist  of  fees  we  charge  to  perform  software  development,  integration,  installation,  and  customization 
services.  Similar  to  software  license  revenue,  services  revenue  depends  on  our  ability  to  win  biometrics  systems 
projects either directly with government customers or in conjunction with channel partners.  Services revenue will 
fluctuate when we commence new projects and/or when we complete projects that were started in previous periods. 

25

Services  increased  64%  from  $3.1  million  in  2013  to  $5.2  million  in  2014.    As  a  percentage  of  total  revenue, 
services increased from 16% in 2013 to 22% in 2014.  The dollar increase in services revenue was due to: i) a $1.6 
million increase from direct government customers; and ii) a $0.4 million increase from channel partners and direct 
commercial customers.  The increase in direct government services was primarily due to a significant project with a 
U.S. government customer that commenced in the third quarter of 2013 and continued throughout 2014. This project 
is currently scheduled to end in March 2015, which means that services revenue may decline in 2015 unless we can 
replace  the  loss  of  revenue  from  this  customer  with  services  revenue  from  other  customers.    The  $0.4  million 
increase in services revenue from channel partners and direct commercial customers was attributable to an increase 
in projects with a number of customers in 2014 as opposed to large projects with a small number of customers. 

Services  increased  22%  from  $2.6  million  in  2012  to  $3.1  million  in  2013.    As  a  percentage  of  total  revenue, 
services increased from 15% in 2012 to 16% in 2013.  The dollar increase in services revenue was primarily due to a 
significant project with a new U.S. government customer that commenced in 2013. As of December 31, 2013, we 
had $2.2 million of services revenue in backlog with this customer, which we expect to deliver in 2014.  Services 
revenue derived from all other government customers and channel partners in 2012 and 2013 was approximately the 
same in both years. 

Hardware 

Hardware  revenue  consists  of  sales  of  biometrics  equipment  to  a  single  U.S.  government  customer  for  whom  we 
developed biometrics software.  Hardware products sold to this customer integrate hardware purchased from third 
parties  with  software  from  other  third  parties  as  well  as  software from  Aware.  We  evaluated  the  classification  of 
gross versus net revenue recognition and determined gross recognition was appropriate.   

Hardware  revenue  increased  55%  from  $3.2  in  2013  to  $4.9  million  in  2014.    As  a  percentage  of  total  revenue, 
hardware revenue increased from 16% in 2013 to 21% in 2014.  The dollar increase in hardware revenue was due to
an increase in units ordered by our U.S. government hardware customer during 2014. 

We  are  unable  to  predict  future  hardware  revenue  with  any  degree  of  certainty  because:  i)  our  contract  with  the 
government  provides  pricing,  but  does  not  obligate  it  to  purchase  any  products  until  it  provides  us with  purchase 
orders; and ii) forecasting our customer’s demand is difficult.  Moreover, future orders from this customer may be 
minimal  as  we  believe  that  the  bulk  of  its  purchases  may  have  already  occurred.    We  have  no  order  backlog  for 
hardware products as of December 31, 2014.   

Hardware revenue increased from $0 in 2012 to $3.2 million in 2013.  As a percentage of total revenue, hardware 
revenue  increased  from  0%  in  2012  to  16%  in  2013.    The  dollar  increase  in  hardware  revenue  was  due  to  the 
commencement of shipments in 2013.  

Royalties 

Royalties  consist  primarily  of  royalty  payments  we  receive  under  DSL  silicon  contracts  with  two  customers  that 
incorporate our silicon intellectual property (“IP”) in their DSL chipsets.  We sold the assets of our DSL IP business 
in 2009, but we continue to receive royalty payments from these customers.  Royalties are reported in continuing 
operations  in  accordance  with  ASC  205-20,  Reporting  Discontinued  Operations,  because  we  have  continuing 
ongoing cash flows from this business. 

Royalties  decreased  21%  from  $0.9  million  in  2013  to  $0.7  million  in  2014.  As  a  percentage  of  total  revenue, 
royalties decreased from 5% in 2013 to 3% in 2014.  The dollar decrease in royalties was primarily due to lower 
DSL royalties from both of our licensees. 

Royalties  decreased  58%  from  $2.2  million  in  2012  to  $0.9  million  in  2013.  As  a  percentage  of  total  revenue, 
royalties decreased from 12% in 2012 to 5% in 2013.  The dollar decrease in royalties was primarily due to lower 
DSL  royalties  from  both  of  our  licensees. One  of our  licensees  achieved  chipset  sales  that  exceeded  certain  sales 
thresholds  in  our  contractual  arrangement  in  late  2012.  The  achievement  of  those  sales  thresholds  triggered 
reductions  in  the  royalty  rate  it  is  required  to  pay  on  certain  products  and  eliminated  them  altogether  on  other 
products.  Our other licensee also reported lower royalties to us in 2013. 

26

We believe it is likely that royalties will continue to decline in future quarters. 

Cost of Hardware 

Cost  of  hardware  consists  primarily  of  the  cost  of  third  party  equipment  and  software  included  in  hardware 
shipments. 

Cost  of  hardware  increased  by  47%  from  $2.4  million  in  2013  to  $3.5  million  in  2014.    Cost  of  hardware  as  a 
percentage  of  hardware  revenue  decreased  from  74%  in  2013  to  71%  in  2014,  which  means  that  product  gross 
margins increased from 26% in 2013 to 29% in 2014.  The dollar increase in cost of hardware was due to higher unit 
shipments of hardware products in the current year periods compared to the prior year period. 

Cost of hardware increased from $0 in 2012 to $2.4 million in 2013. Cost of hardware as a percentage of hardware 
revenue were 74% in 2013, which means that gross margins on hardware revenue were 26%. The dollar increase in 
cost of hardware was due to the commencement of hardware shipments in 2013. 

Cost of Services 

Cost of services consists of engineering costs to perform customer services projects.  Such costs primarily include: i) 
engineering  salaries,  stock-based  compensation,  fringe  benefits,  and  facilities;  and  ii)  engineering  consultants  and 
contractors. 

Cost of services increased 57% from $1.5 million in 2013 to $2.4 million in 2014. Cost of services as a percentage 
of services decreased from 48% in 2013 to 46% in 2014, which means that gross margins on services increased from 
52% to 54%. The dollar increase in cost of services was attributable to an increase in services revenue. 

Cost  of  services  was  unchanged  at  $1.5  million  in  2012  and  2013.  As  a  percentage  of  services  revenue,  cost  of 
services decreased from 60% in 2012 to 48% in 2013, which means that gross margins on services increased from 
40% to 52%.  

Gross  services  margins  of  54%,  52%,  and  40%  in  2014,  2013  and  2012,  respectively,  were  a  function  of:  i)  the 
nature of the projects; ii) the level of engineering difficulty and labor hours required to complete project tasks; and 
iii)  how  much  we  were  able  to  charge.    Gross  margins  in  these  years  reflect  the  profitability  mix  of  customer 
projects. We expect that gross margins on services will continue to fluctuate in future periods based on the nature, 
complexity, and pricing of future projects. 

Research and Development Expense 

Research  and  development  expense  consists  of  costs  for:  i)  engineering  personnel,  including  salaries,  stock-based 
compensation, fringe benefits, and facilities; ii) engineering consultants and contractors, and iii) other engineering 
expenses such as supplies, equipment depreciation, dues and memberships and travel.  Engineering costs incurred to 
develop our technology and products are classified as research and development expense. As described in the cost of 
services section, engineering costs incurred to provide engineering services for customer projects are classified as 
cost of services, and are not included in research and development expense. 

The  classification  of  total  engineering  costs  to  research  and  development  expense  and  cost  of  services  was  (in 
thousands): 

  Research and development expense ............................
  Cost of services ...........................................................
     Total engineering costs ............................................

Years ended December 31, 
2014 
$5,505 
2,359 
$7,864 

2013 
$4,085 
1,503 
$5,588 

2012 
$3,489 
1,542 
$5,031 

27

 
 
 
 
 
 
Research  and  development  expense  increased  35%  from  $4.1  million  in  2013  to  $5.5  million  in  2014.    As  a 
percentage of total revenue, research and development expense increased from 21% in 2013 to 23% in 2014 

As the table above indicates, total engineering costs increased from $5.6 million in 2013 to $7.9 million in 2014.  
The  spending  increase  was  primarily  due  to  the  hiring  of  engineering  employees  and  contractors.  In  the  last  18 
months,  engineering  headcount,  excluding  contractors,  grew  from  30  employees  as  of  June  30,  2013  to  48 
employees as of December 31, 2014.  The expansion of our engineering organization was designed to provide the 
resources we required to: i) pursue new product development initiatives; and ii) staff customer engineering services 
projects.

Research  and  development  expense  increased  17%  from  $3.5  million  in  2012  to  $4.1  million  in  2013.    As  a 
percentage of total revenue, research and development expense increased from 20% in 2012 to 21% in 2013.   

As the table above indicates, total engineering costs increased from $5.0 million in 2012 to $5.6 million in 2013.  
The  dollar  increase  in  research  and  development  expense  in  2013  was  primarily  due  to  headcount  growth  in  our 
engineering  organization,  which  was  partially  offset  by  lower  expenses  related  to  a  former  employee  who  was 
involved with the effort to monetize patents who left the company in 2012. 

As we described in the strategy section in Part 1 of this Form 10-K, we intend to introduce new products that will 
allow us to offer more complete biometrics solutions. We believe this strategy will allow us to sell more software 
into  biometrics  systems  projects  in  order  to  grow  our  revenue.    Our  preference  is  to  develop  such  products 
internally,  however  to  the  extent  we  are  unable  to  do  that,  we  may  purchase  or  license  technologies  from  third 
parties.  The engineering spending increases in 2013 and 2014 are a reflection of that strategy.  We anticipate that 
we  will  continue  to  focus  our  future  research  and  development  activities  on  enhancing  existing  products  and 
developing new products. 

Selling and Marketing Expense 

Selling and marketing expense primarily consists of costs for: i) sales and marketing personnel, including salaries, 
sales  commissions,  stock-based  compensation,  fringe  benefits,  travel,  and  facilities;  and  ii)  advertising  and 
promotion expenses. 

Sales and marketing expense increased 12% from $3.3 million in 2013 to $3.7 million in 2014.   As a percentage of 
total  revenue,  sales  and  marketing  expense  decreased  from  18%  in  2013  to  16%  in  2014.    The  dollar  increase  in 
selling and marketing expense was primarily due to higher sales commissions on higher revenue in 2014, and the 
addition of one sales and marketing employee in early 2014. 

Selling  and  marketing  expense  was  essentially  unchanged  at  approximately  $3.3 million  in 2012  and 2013.   As a 
percentage  of  total  revenue,  selling  and  marketing  expense  decreased  from  20%  in  2012  to  18%  in  2013.  
Unchanged selling and marketing expense reflects two sets of offsetting factors.  Expenses increased due to growth 
in  our  sales  organization,  but  those  increases  were  mostly  offset  by  lower  expenses  related  to  a  former  employee 
who was involved with the effort to monetize patents who left the company in 2012. Expense growth in the sales 
organization was driven by new sales employees, foreign sales agents, and higher sales commissions. 

General and Administrative Expense 

General  and  administrative  expense  consists  primarily  of  costs  for:  i)  officers,  directors  and  administrative 
personnel,  including  salaries,  bonuses,  director  compensation,  stock-based  compensation,  fringe  benefits,  and 
facilities;  ii)  professional  fees,  including  legal  and  audit  fees;  iii)  public  company  expenses;  and  iv)  other 
administrative expenses, such as insurance costs and bad debt provisions. 

General  and  administrative  expense  increased  4%  from  $3.5  million  in  2013  to  $3.7  million  in  2014.    As  a 
percentage of total revenue, general and administrative expense decreased from 18% in 2013 to 15% in 2014.  The 
increase  in  general  and  administrative  expense  in  2014  was  primarily  due  to  an  increase  in  stock-based 
compensation which was partially offset by lower patent filing expenses. 

General  and  administrative  expense  decreased  9%  from  $3.9  million  in  2012  to  $3.5  million  in  2013.    As  a 
percentage of total revenue, general and administrative expense decreased from 22% in 2012 to 18% in 2013.  The 
28

dollar decrease in general and administrative expense was primarily due to two sets of offsetting factors.  Expenses 
decreased  due  to  lower:  i)  patent  prosecution  legal  fees;  ii)  audit  fees;  and  iii)  general  corporate  legal  fees.  Such 
expense reductions were partially offset by stock-based compensation costs associated with a stock grant to directors 
and officers in April 2013. 

Patent Related Income 

Patent related income in the years ended December 31, 2014, 2013 and 2012 was derived from either gains on the 
sale  of  patent  assets  or  income  from  a  patent  arrangement,  or  both.  Income  from  these  sources  was  included  in 
income  from  continuing  operations  pursuant  to  ASC  360-10,  Impairment  or  Disposal  of  Long-Lived  Assets,  and 
Rule 5-03 of Regulation S-X. 

The composition of patent related income in 2014, 2013, and 2012 was as follows: 

Year ended December 31, 2014. We had a $2.1 million gain on the sale of patent assets and no income from our 
patent arrangement in 2014. The gain on the sale of patent assets is described below: 

We sold a portion of our patent portfolio pertaining to DSL diagnostic technology to an unrelated third party for 
$2.6  million.  The  proceeds  from  the  sale  were  reduced  by  $0.5  million  of  transaction  costs,  which  consisted 
primarily of fees from the law firm that assisted us in the sale.  We recorded a gain of $2.1 million on the sale. 

The  DSL  diagnostic  technology  in  the  patents  we  sold  in  2014  was  related  to  our  DSL  Service  Assurance 
business that we shut down in 2012 and 2013 and reported in discontinued operations in those periods. We do 
not consider our patent related activities to be a component of the operating business from which the underlying 
technology  was  derived,  but  rather  as  a  component  of  corporate  general  and  administrative  expenses.  
Accordingly the gain on the sale of these patents was reported in income from continuing operations.   

Year ended December 31, 2013. We had $0.8 million of income from a patent arrangement and no gains on the sale 
of patent assets in 2013.  Income from the patent arrangement is described below: 

We entered into an arrangement with an unaffiliated third party in 2010 under which we assigned certain patents 
in  return  for  royalties  on  proceeds  from  patent  monetization  efforts  by  the  third  party.    Such  third  party  has 
engaged  in  various  patent  monetization  activities,  including  enforcement,  litigation  and  licensing.  The  party 
reported and we recorded $0.8 million of income from this arrangement in the year ended December 31, 2013. 

We  continue  to  have  a  contractual  relationship  with  this  third  party.  However,  we  are  unable  to  predict  how 
much more income we might receive from this arrangement, if any, because:  

(cid:120)

The  claims  in  one  of  the  patents  we  assigned  were  rejected  by  the  United  States  Patent  Office 
(“USPTO”) in May 2013. The USPTO’s Patent Trial & Appeal Board (“PTAB”) affirmed the USPTO 
decision in June 2014.  The PTAB decision was appealed to the Federal Circuit.  In December 2014, 
the Federal Circuit remanded the appeal back to the PTAB for further consideration. 

(cid:120) Notwithstanding the outcome at the PTAB, we do not know whether any patent monetization efforts 

by the third party will be successful. 

Year ended December 31, 2012. We had total patent related income of $87.5 million in 2012, which consisted of 
$86.4 million of gains on the sale of patent assets and $1.1 million of income from our patent arrangement. Patent 
related income in 2012 is described below: 

Gains  on  the  sale  of  patent  assets.  Total  gains  on  the  sale  of  patent  assets  in  2012  were  $86.4  million,  which 
consisted  of  gains  from  two  separate  sales.    Gains  from  both  sales  were  recorded  in  income  from  continuing 
operations as none of these patents were related to any discontinued operations, including our discontinued DSL 
Service Assurance business.  The two sales are described below: 

(cid:120) We sold a portion of our patent portfolio pertaining to wireless technology to an unaffiliated third party 
for $75.0 million. The proceeds from the sale were reduced by $3.8 million of transaction costs, which 
consisted primarily of fees from the law firm that assisted us in the sale.  We recorded a gain of $71.2 
million on the sale. 

29

(cid:120) We  sold  a  portion  of  our  patent  portfolio  pertaining  to  DSL  semiconductor  intellectual  property 
technology for $16.0 million. The proceeds from the sale were reduced by $0.8 million of transaction 
costs,  which  also  consisted  primarily  of  fees  from  the  law  firm  that  assisted  us  in  the  sale.    We 
recorded a gain of $15.2 million on the sale. 

Income from patent arrangement.  The third party to whom we assigned patents reported and we recorded $1.1 
million of income from this arrangement in the year ended December 31, 2012.

Other Income/(Expense) 

We  recorded  other  expense  of  $59,000  in  the  year  ended  December  31,  2014,  and  other  income  of  $23,000  and 
$85,000 in the years ended December 31, 2013 and 2012, respectively. Other income or expense in all three years 
consisted of realized gains or losses on sales or calls of high yield bond investments. 

Interest Income 

Interest income decreased 31%, or $103,000, from $328,000 in 2013 to $225,000 in 2014.  The dollar decrease was 
primarily due to i) lower levels of high yield bond investments held in 2014 as compared to 2013; and ii) lower cash 
balances as a result of a $39.9 million dividend payment in July 2014. 

Interest income increased 44%, or $101,000, from $227,000 in 2012 to $328,000 in 2013.  The dollar increase was 
primarily due to interest income from high yield bonds as we held more bonds in 2013 than 2012. 

Income Taxes 

We are subject to income taxes in the United States and we use estimates in determining our provisions for income 
taxes. We account for income taxes using the asset and liability method for accounting and reporting income taxes. 
Deferred tax assets and liabilities are recognized based on temporary differences between the financial reporting and 
income tax bases of assets and liabilities using statutory rates.  

A discussion of income taxes for the years ended December 31, 2014, 2013, and 2012 follows: 

Year ended December 31, 2014.  Total income tax expense for the year ended December 31, 2014 was $2.7 million, 
all of which was recorded in continuing operations.  Income tax expense for 2014 was based on the U.S. statutory 
rate  of  34%,  increased  by  state  income  taxes,  and  reduced  by  Federal  research  tax  credits  and  permanent 
adjustments. 

As  of  December  31,  2014,  we  had  a  total  of  $1.0  million  of  deferred  tax  assets  for  which  we  had  recorded  no 
valuation allowance.  We will continue to assess the level of valuation allowance in future periods.  Should evidence 
regarding  the  realizability  of  tax  assets  change  at  a  future  point  in  time,  the  valuation  allowance  will  be  adjusted 
accordingly.

In  addition  to  deferred  tax  assets  carried  on  our  balance  sheet,  we  also  had  net  federal  and  state  research  and 
development credit carryforwards available at December 31, 2014 of $4.0 million and $0.3 million. These credits 
were not recorded as tax assets as they relate to excess stock compensation deductions that may not be recorded as 
tax  assets  under  generally  accepted  accounting  principles  until  the  amounts  have  been  utilized  to  reduce  our  tax 
liability. To the extent that these assets can be used to reduce taxes, the benefit must be recorded as a reduction to 
additional paid-in capital. In 2014, we recorded a tax benefit of $1.2 million to equity related to the use of these tax 
credits to reduce our tax liability.   

In 2014, the Internal Revenue Service commenced an examination of our tax return for the year ended December 31, 
2012. 

Year ended December 31, 2013. Total income tax expense for the year ended December 31, 2013 was $1.2 million, 
including $1.9 million that was recorded in continuing operations less a tax benefit of $0.7 million that was recorded 
in discontinued operations. Income tax expense for 2013 was based on the U.S. statutory rate of 34%, increased by 

30

state  income  taxes,  and  reduced by  Federal  research  tax credits  and permanent  adjustments.  Tax  expense  in 2013 
also reflects two items related to 2012, including: i) a tax benefit of $95,000 related to the 2012 research tax credit. 
This  credit  was  extended  retroactively  back  to  January 1,  2012,  by  the  American  Taxpayer  Relief  Act  of  2012, 
which was enacted on January 2, 2013; and ii) a tax benefit of $148,000 related to a reduction in the estimate of the 
2012 tax expense recorded in our 2012 financial statements. 

In 2013, we recorded a tax benefit of $128,000 that reduced our tax liability.  This benefit was recorded in equity as 
it was related to federal and state research tax credits that represented excess stock compensation deductions. 

Year  ended  December  31,  2012.    Total  income  tax  expense  for  the  year  ended  December  31,  2012  was  $20.4 
million, including $20.5 million that was recorded in continuing operations less a tax benefit of $51,000 that was 
recorded in discontinued operations. The Company’s actual tax liability for 2012 was $7.8 million as taxes that were 
currently payable were reduced by a $14.4 million equity adjustment. This equity adjustment is described more fully 
below.  

In 2012, we used a significant portion of our available deferred tax assets to reduce income taxes on pre-tax income. 
A  substantial  portion  of  the  deferred  tax  assets  we  utilized  comprised  cumulative  deductions  for  stock  options  in 
excess  of  book  expense.  Under  income  tax  accounting  rules,  the  portion  of  tax  benefits  attributable  to  such 
deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. In the year ended 
December  31, 2012,  the  tax benefits  from  such  stock-based  awards  were  $14.4  million,  which  we  recorded  as  an 
equity adjustment to additional paid-in capital. 

Income tax expense in 2012 was also reduced by a $1.8 million reversal of the valuation allowance on our remaining 
deferred tax assets at December 31, 2012. We reversed the valuation allowance because based on all the available 
evidence, we believed that it is more likely than not that our deferred tax assets will be realizable.  In reaching this 
determination,  we  evaluated:  i)  our  most  recent  years  operating  results;  ii)  our  future  financial  plans;  and  iii)  the 
nature of the components comprising deferred tax assets at December 31, 2012. 

Loss from discontinued operation, net of income taxes.

Loss  from  discontinued  operations,  net  of  income  taxes  reflects  results  from  our  discontinued  DSL  Service 
Assurance Segment. This segment includes results from our DSL hardware and software product lines that we shut 
down in 2012 and 2013, respectively.  Loss from such discontinued operations was (in thousands): 

Years ended December 31, 
2013 

2014 

2012 

  Revenue .......................................................................
  Expenses .....................................................................
     Loss before income taxes .........................................
  Income tax benefit  ......................................................
     Loss from discontinued operations ..........................

$- 
- 
- 
- 
$- 

$3,216 
5,120 
(1,904) 
(748) 
($1,156) 

$5,431 
5,558 
(127) 
(51) 
($76) 

31

 
 
LIQUIDITY AND CAPITAL RESOURCES

In recent years, we have financed the company with our cash balances, cash generated from operations, and cash 
received from the sale of patent assets.  Equity financing has not been a meaningful source of financing for us in 
recent years. Cash flows from operating, investing and financing activities are described below. 

Cash flow from operating activities 
In the years ended December 31, 2014 and 2013, our operating activities provided net cash of $6.3 million and $2.8 
million, respectively.  In the year ended December 31, 2012, our operating activities used net cash of $15.3 million. 
A discussion of cash flow from operating activities for each of the last three years follows: 

Year ended December 31, 2014. Cash provided by operating activities of $6.3 million in 2014 was primarily the 
result  of  net  income  of  $4.6  million,  which  was  increased  for  non-cash  items  related  to  depreciation  and 
amortization of $0.5 million and stock-based compensation expense of $0.9 million.  Cash provided by operating 
activities also included $2.4 million of cash that came from a reduction of working capital items. Cash provided 
by these sources was partially offset by a $2.1 million gain on the sale of patent assets that was included in $4.6 
million of net income, but was included in cash flow from investing activities in the statements of cash flow. 

Year ended December 31, 2013. Cash provided by operations of $2.8 million in 2013 was primarily the result of 
net income of $2.6 million, which was increased for non-cash items related to depreciation and amortization of 
$0.5  million  and  stock-based  compensation  expense  of  $0.7  million.    Cash  provided  from  these  sources  was 
partially offset by $1.0 million of net cash used to fund working capital items. 

Year  ended  December  31,  2012.  Cash  used  by  operating  activities  of  $15.3  million  in  2012  was  primarily  the 
result of:  i)  cash provided  by  on-going operations  of $6.7  million;  less  ii)  income  tax  items  on  patent  sales  of 
$22.0 million.  A discussion of each of these factors follows: 

(cid:120)

(cid:120)

Cash  provided  by  on-going  operations  of  $6.7  million  was  the  result  of:  i)  operating  income  before 
patent  related  income  of  $5.0  million;  ii)  interest  income  and  other  income  of  $0.3  million;  iii) 
adjustments for non-cash items related to depreciation and stock-based compensation of $0.5 million 
and $0.3 million, respectively; and iv) changes in working capital components that increased cash by 
$0.6 million. 

Cash  provided  by  on-going  operations  of  $6.7  million  was  reduced  by  $22.0  million  of  income  tax 
items that were incurred as a result of our patent sales in 2012. The $22.0 million of income tax items 
comprises: i) $7.6 million of tax payments; and ii) $14.4 million of tax expense that is reduced by a tax 
benefit  from  excess  stock-based  compensation  that  must  be  presented  as  cash  flows  from  financing 
activities under generally accepted accounting principles as opposed to an item that benefits cash flows 
from operating activities. 

Cash flow from investing activities 
In the year ended December 31, 2014 and 2012, our investing activities provided net cash of $3.4 million and $85.1 
million, respectively.  In the year ended December 31, 2013, our investing activities used net cash of $1.4 million.  
A discussion of cash flow from investing activities for each of the last three years follows: 

Year ended December 31, 2014. Cash provided by investing activities of $3.4 million in 2014 was primarily the 
result of $2.1 million of net proceeds from the sale of patent assets and $1.4 million of proceeds from the sale of 
investments.  Cash provided from these sources was partially offset by $0.1 million of capital expenditures. 

Year  ended  December  31,  2013.  Cash  used  by  investing  activities  of  $1.4  million  in  2013  was  primarily  the 
result of $0.2 million of capital expenditures, $0.9 million of net investment purchases, and $0.3 million used to 
purchase other assets. 

Year ended December 31, 2012. Cash provided by investing activities of $85.1 million in 2012 was primarily 
due to $86.4 million of net proceeds from the sale of patent assets.  Cash provided from the sale of patent assets 
was reduced by: i) $0.1 million of capital expenditures; and ii) $1.2 million of net investment purchases.

We have no material commitments for capital expenditures.  

32

Cash flow from financing activities 
In the years ended December 31, 2014 and 2012, our financing activities used net cash of $38.4 million and $45.3 
million, respectively.  In the year ended December 31, 2013, our financing activities provided net cash of $122,000. 
A discussion of cash flow from financing activities for each of the last three years follows: 

Year ended December 31, 2014. Cash used by financing activities of $38.4 million in 2014 was primarily the 
result  of  a  $39.9  million  dividend  payment  and  $0.2  million  used  to  repurchase  stock  from  employees  in 
connection with stock issuances under a stock grant program. Cash used by these two items was partially offset 
by:  i)  a  $1.2 million  tax benefit  related  to  excess  stock-based  compensation;  and  ii)  $0.5  million  of  proceeds 
from the exercise of stock options. 

Year ended December 31, 2013. Cash provided by financing activities of $122,000 in 2013 was primarily the 
result  of  $65,000  of  proceeds  from  the  issuance  of  stock  under  employee  stock  programs  and  $128,000  of 
excess tax benefits from stock-based compensation. Cash provided by these two factors was partially offset by 
$71,000 used to repurchase stock from employees in connection with stock issuances under a 2013 stock grant. 

Year ended December 31, 2012. Cash used by financing activities of $45.3 million in 2012 was primarily the 
result  of  $66.0  million  of  dividend  payments  and  $0.2  million  used  to  repurchase  stock  from  employees  in 
connection  with  stock  issuances  under  a  stock  grant  program.  Cash  usage  by  these  two  factors  was  partially 
offset  by:  i)  $6.5  million  of  proceeds  from  the  exercise  of  stock  options;  and  ii)  a  $14.4  million  tax  benefit 
related to excess stock-based compensation. 

At December 31, 2014, we had cash and cash equivalents of $44.0 million and investments of $1.4 million.  While 
we cannot assure you that we will not require additional financing, or that such financing will be available to us, we 
believe that our cash and cash equivalents and investments will be sufficient to fund our operations for at least the 
next twelve months. 

To date, inflation has not had a material impact on our financial results.  There can be no assurance, however, that 
inflation will not adversely affect our financial results in the future.

33

OFF-BALANCE SHEET ARRANGEMENTS 

We  do  not  currently  have  any  arrangements  with  unconsolidated  entities,  such  as  entities  often  referred  to  as 
structured finance, special purpose entities, or variable interest entities which are often established for the purpose of 
facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.  Accordingly, we are 
not exposed to any financing, liquidity, market or credit risk if we had such relationships.

In 2011 and 2012, we disclosed that we had a patent arrangement with an unaffiliated third party that we classified 
as a variable interest entity (“VIE”).  Under this arrangement we assigned certain patents to the third party, the third 
party engages in monetization activities and shares royalties with us.  The third party is engaged in the business of 
the monetization of intellectual property. We continue to have a contractual relationship with this third party. 

We  also  disclosed  in  those  years  that:  i)  we  had  no  equity  interest  in  the  entity;  ii)  we  were  not  contractually 
obligated to fund the entity, therefore our maximum exposure to loss as a result of our involvement with the entity 
was  zero;  iii)  we  may  receive  royalties  in  the  future  if  certain  conditions  are  met;  iv)  we  were  not  the  primary 
beneficiary of the entity; v) we had not consolidated the entity’s results into our financial statements, therefore we 
carried the assets and liabilities of this entity in our balance sheet at zero; and vi) prior to September 30, 2012, this 
arrangement had no impact on our results of operations, financial position or cash flows in any previous periods. 

We  determined  that  the  third  party  entity  was  a  VIE  in  2011  and  2012,  because  we  made  a  judgment  that  the 
arrangement met two conditions under ASC 810, Consolidation, that caused VIE classification, namely: i) our right 
to receive royalties entitled us to receive a portion of the entity’s expected residual returns; and ii) a provision in the 
agreement denied the equity holders of the third party entity the power to direct the activities that most significantly 
impacted the entity’s economic performance. 

We also determined at that time that we were not the primary beneficiary because: i) we had no equity interest in the 
third party entity; and ii) a provision in the agreement resulted in “shared power” that did not give either party the 
power to direct the activities that most significantly impacted the economic performance of the entity.  Accordingly, 
we  were  not  required  to  consolidate  the  third  party  entity  under  ASC  810,  because  we  were  not  the  primary 
beneficiary. 

Due  to  strategic  legal  reasons,  we  found  it  necessary  to  amend  the  agreement  in  August  2012  to  eliminate  the 
provision that had previously denied the equity holders of the third party entity the power to direct the activities that 
most significantly impacted the entity’s economic performance.  Upon amendment, the equity holders of the entity 
had such power, and we determined that the arrangement was no longer a VIE under ASC 810. 

34

CONTRACTUAL OBLIGATIONS 

We  have  various  contractual  obligations  impacting  our  liquidity.    The  following  represents  our  contractual 
obligations as of December 31, 2014 (in thousands): 

Contractual Obligations 

Total 

1 year 

1-3 years 

3-5 years 

5 years 

Payments Due By Period 

  Less than 

  More than 

Purchase orders 
Total 

      $52 
        $52 

      $52 
        $52 

 $- 
 $- 

$- 
 $- 

$- 
 $- 

CRITICAL ACCOUNTING POLICIES

We  consider  certain  accounting  policies  related  to  revenue  recognition,  stock-based  compensation,  income  taxes, 
and the allowance for doubtful accounts to be critical policies.  

Revenue recognition.  We derive revenue from five sources: (i) software licenses; (ii) software maintenance; (iii) 
software services; iv) hardware; and (v) royalties. 

We recognize revenue when there is persuasive evidence of an arrangement, the sales price is fixed or determinable, 
collection of the related receivable is reasonably assured, and delivery has occurred or services have been rendered.  
As  described below,  we  make  significant  judgments  during  the process  of  determining  revenue  for any  particular 
accounting period.   

In  determining  revenue  recognition,  we  assess  whether  fees  associated  with  revenue  transactions  are  fixed  or 
determinable based on the terms of the contract and based on payment terms. If the fee is not fixed or determinable, 
we  defer  the  fee  and  recognize  revenue  as  amounts  become  due  and  payable.  We  assess  whether  collection  is 
reasonably assured based on a number of factors, including past transaction history with the customer and the credit-
worthiness of the customer.  If we determine that collection of a fee is not reasonably assured, we defer the fee and 
recognize revenue at the time collection becomes reasonably assured. 

We  must  also  make  judgments  with  respect  to  the  recognition  of  revenue  for  multiple  element  revenue 
arrangements. We recognize revenue for multiple element arrangements as follows:  

Software and software related multiple element arrangements: 

We sell software licenses, software maintenance and software services in various combinations of multiple element 
arrangements.  We  apply  the  provisions  of  ASC  985-605,  Software  Revenue  Recognition,  to  these  arrangements 
because  all  the  elements  are  software  or  software  related.    The  various  combinations  of  multiple  element 
arrangements and our revenue recognition for each are described below: 

o When  software  licenses  and  maintenance  contracts  are  sold  together,  we  recognize  software  license  revenue 
upon  delivery,  provided  we  have  vendor  specific  objective  evidence  (“VSOE”)  for  the  fair  value  of  the 
maintenance  contract  fee,  and  we  recognize  the  fair  value  of  maintenance  contract  revenue  ratably  over  the 
related contract period. 

o When software engineering services and software licenses are sold together, the total fee is generally recognized 
by  applying  contract  accounting.    We  have  adopted  the  percentage-of-completion  method  of  contract 
accounting, and we primarily use an input method (i.e., labor hours) to determine our completion percentage.  

o When we sell software licenses, software maintenance, and software services together, revenue is recognized as 
follows:  i)  maintenance  revenue  is  separated  from  the  other  two  elements  and  is  recognized  ratably  over  the 
related contract period; provided we have VSOE for the fair value of the maintenance element; and ii) the total 
fee  from  the  software  license  and  engineering  service  elements  is  recognized  by  applying  the  contract 
accounting method described in the previous paragraph. 

35

 
 
  
 
 
 
 
  
 
 
 
 
Hardware and software multiple element arrangements: 

o We  also  have  a  multiple  element  arrangement  with  one  customer  that  involves  the  delivery  of  hardware, 
software maintenance, and software services.  We determined that these elements qualified as separate units of 
accounting  under  ASC  605,  Revenue  Recognition,  because  they  have  value  to  the  customer  on  a  standalone 
basis.    Accordingly,  we  recognize  hardware  revenue  upon  delivery  and  acceptance  by  the  customer, 
maintenance revenue ratably over the related contract period, and service revenue as services are delivered. 

Our revenue recognition policies are described more fully in Note 2, Summary of Significant Accounting Policies, 
in the Notes to our Consolidated Financial Statements. 

Stock-Based  Compensation.      We  grant  stock  and  stock  options  to  our  employees  and  directors,  although  stock 
option grants in recent years have been minimal.  We measure stock-based compensation cost at the grant date based 
on the fair value of the award and recognize it as expense over the applicable vesting period of the award using the 
straight-line basis.  

For stock awards, we determine the fair value of the award by using the fair market value of our stock on the date of 
grant; provided the number of shares in the grant is fixed on the grant date. 

For stock options, we use the Black-Scholes valuation model to estimate the fair value of the award. This valuation 
model  takes  into  account  the  exercise  price  of  the  award,  as  well  as  a  variety  of  significant  assumptions.    The 
assumptions used to estimate the fair value of stock options include the expected term, the expected volatility of our 
stock over the expected term, the risk-free interest rate  over the expected term, and our expected annual dividend 
yield.   

Income taxes.  As part of the process of preparing our consolidated financial statements we are required to estimate 
our  actual  current  tax  expense.    We  must  also  estimate  temporary  and  permanent  differences  that  result  from 
differing treatment of certain items for tax and accounting purposes.  These differences result in deferred tax assets 
and liabilities, which are included in our consolidated balance sheet.  We must then assess the likelihood that our 
deferred tax assets will be recovered from future taxable income and to the extent we believe recovery is not likely, 
we  must  establish  a  valuation  allowance.    To  the  extent  we  establish  a  valuation  allowance  or  increase  this 
allowance in a period for deferred tax assets, which have been recognized, we must include an expense with the tax 
provision in the statement of operations.  Conversely, to the extent we decrease our valuation allowance in a period 
for deferred tax assets, which have been previously reserved, we must include a tax benefit with the tax provision in 
the statement of operations. 

Significant management judgment is required in determining our provision for income taxes, our deferred tax assets, 
and any valuation allowance recorded against our net deferred tax assets.  Our deferred tax assets primarily relate to 
temporary  differences  that result  from  differing  treatment of  certain  items  for  tax  and  accounting purposes.  As of 
December 31, 2014, we had a total of $1.0 million of deferred tax assets for which we had recorded no valuation 
allowance.  

We will continue to assess the level of valuation allowance required in future periods. Should evidence regarding the 
realizability of tax assets change at a future point in time, the valuation allowance will be adjusted accordingly.  

Allowance  for  doubtful  accounts.    We  make  judgments  as  to  our  ability  to  collect  outstanding  receivables  and 
provide allowances for receivables when collection becomes doubtful.  Provisions are made based upon a specific 
review of all significant outstanding invoices.  If the judgments we make to determine the allowance for doubtful 
accounts  do  not  reflect  the  future  ability  to  collect  outstanding  receivables,  additional  provisions  for  doubtful 
accounts may be required. 

36

RECENT ACCOUNTING PRONOUNCEMENTS

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). The ASU is the 
result  of  a  joint  project  by  the  FASB  and  the  International  Accounting  Standards  Board  (“IASB”)  to  clarify  the 
principles for recognizing revenue and to develop a common revenue standard for GAAP and International Financial 
Reporting  Standards  (“IFRS”)  that  would:  remove  inconsistencies  and  weaknesses,  provide  a  more  robust 
framework  for  addressing  revenue  issues,  improve  comparability  of  revenue  recognition  practices  across  entities, 
jurisdictions,  industries,  and  capital  markets,  improve  disclosure  requirements  and  resulting  financial  statements, 
and simplify the presentation of financial statements. The core principle of the new guidance is that an entity should 
recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the 
consideration  to  which  the  entity  expects  to  be  entitled  in  exchange  for  those  goods  or  services.  The  ASU  is 
effective for annual reporting periods beginning after December 15, 2016.  Early adoption is not permitted. We are 
currently  evaluating  the  effect  that  the  updated  standard  will  have  on  our  consolidated  financial  statements  and 
related disclosures. 

With  the  exception  of  the  new  revenue  standard  discussed  above,  there  have  been  no  other  recently  issued 
accounting pronouncements that are of significance or potential significance to us that we have not adopted as of 
December 31, 2014. 

ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our exposure to market risk relates primarily to our investment portfolio, and the effect that changes in interest rates 
would have on that portfolio. Our investment portfolio at December 31, 2014 consisted of two elements: 

1. Cash  and  cash  equivalents.  As  of  December  31,  2014,  our  cash  and  cash  equivalents  of  $44.0  million  were 
primarily invested in money market funds. The money market funds were invested in high quality, short term 
financial instruments.  Due to the nature, short duration, and professional management of these funds, we do not 
expect that a general increase in interest rates would result in any material loss.

2.

Investments. As of December 31, 2014, our investments of $1.4 million were invested in high yield bonds with 
three corporate debt issuers, which mature in 2017 and 2018.  While we are exposed to default risk, the high 
current yield of these bonds largely mitigates interest rate risk. Therefore, due to the high current yield and the 
two to five year life of these instruments, we do not believe that a general increase in interest rates would result 
in any material loss.  

We do not use derivative financial instruments for speculative or trading purposes.   

37

ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Report of Independent Registered Public Accounting Firm  

Board of Directors and Stockholders of Aware, Inc.: 

We have audited the accompanying consolidated balance sheets of Aware, Inc. (“the Company”) as of December 31, 
2014 and 2013, and the related consolidated statements of income and comprehensive income, stockholders' equity 
(deficit)  and  cash  flows  for  each  of  the  three  years  in  the  period  ended  December  31,  2014  and  the  financial 
statement  schedule  of  Aware,  Inc.  listed  in  Item  15(a).  We  also  have  audited  Aware,  Inc.'s  internal  control  over 
financial  reporting  as  of  December  31,  2014,  based  on  criteria  established  in  Internal  Control  —  Integrated 
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013.  Aware, 
Inc.'s  management  is  responsible  for  these  financial  statements,  for  maintaining  effective  internal  control  over 
financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in 
the  accompanying  Management’s  Report  on  Internal  Control  over  Financial  Reporting.  Our  responsibility  is  to 
express  an  opinion  on  these  financial  statements  and  an  opinion  on  the  Company's  internal  control  over  financial 
reporting based on our audits. 

We  conducted  our  audits  in  accordance  with  the  standards  of  the  Public  Company  Accounting  Oversight  Board 
(United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about 
whether  the  financial  statements  are  free  of  material  misstatement  and  whether  effective  internal  control  over 
financial  reporting  was  maintained  in  all  material  respects.  Our  audits  of  the  financial  statements  included 
examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the 
accounting  principles  used  and  significant  estimates  made  by  management,  and  evaluating  the  overall  financial 
statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of 
internal  control  over  financial  reporting,  assessing  the  risk  that  a  material  weakness  exists,  and  testing  and 
evaluating  the  design  and  operating  effectiveness  of  internal  control  based  on  the  assessed  risk.  Our  audits  also 
included  performing  such  other  procedures  as  we  considered  necessary in  the  circumstances. We believe  that  our 
audits provide a reasonable basis for our opinions. 

A  company's  internal  control  over  financial  reporting  is  a  process  designed  to  provide  reasonable  assurance 
regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for  external  purposes  in 
accordance  with  generally  accepted  accounting  principles.  A  company's  internal  control  over  financial  reporting 
includes  those  policies  and  procedures  that  (a)  pertain  to  the  maintenance  of  records  that,  in  reasonable  detail, 
accurately and fairly reflect the transactions and dispositions of the assets of the company; (b) provide reasonable 
assurance  that  transactions  are  recorded  as  necessary  to  permit  preparation  of  financial  statements  in  accordance 
with generally  accepted  accounting principles,  and  that  receipts  and  expenditures of  the  company  are  being  made 
only  in  accordance  with  authorizations  of  management  and  directors  of  the  company;  and  (c)  provide  reasonable 
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's 
assets that could have a material effect on the financial statements. 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. 
Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become 
inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may 
deteriorate.

In  our  opinion,  the  consolidated  financial  statements  referred  to  above  present  fairly,  in  all  material  respects,  the 
financial position of Aware, Inc. as of December 31, 2014 and 2013, and the consolidated results of its operations 
and  its  cash  flows  for  each  of  the  years  in  the  three-year  period  ended  December  31,  2014,  in  conformity  with 
accounting principles generally accepted in the United States of America, and in our opinion, the related financial 
statement  schedule,  when  considered  in  relation  to  the  basic  consolidated  financial  statements  taken  as  a  whole, 
present fairly in all material respects the information set forth therein. Also in our opinion, Aware, Inc. maintained, 
in all material respects, effective internal control over financial reporting as of December 31, 2014, based on criteria 
established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of 
the Treadway Commission in 2013. 

/s/ McGladrey LLP 
Boston, Massachusetts 
February 13, 2015

38

AWARE, INC. 
CONSOLIDATED BALANCE SHEETS 
(in thousands, except share data)

ASSETS 
Current assets:
     Cash and cash equivalents ........................................................................  
     Accounts receivable (less allowance for doubtful 
        accounts of $20 at December 31, 2014 and 2013) .................................  
     Inventories ................................................................................................  
     Deferred tax assets ....................................................................................  
     Prepaid expenses and other current assets ................................................  
           Total current assets .............................................................................  

Property and equipment, net ..........................................................................  
Investments  ...................................................................................................  
Long term deferred tax assets  .......................................................................  
Other assets ....................................................................................................  
           Total assets ..........................................................................................  

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities: 
     Accounts payable ......................................................................................  
     Accrued expenses .....................................................................................  
     Accrued compensation ..............................................................................  
     Accrued professional fees .........................................................................  
     Deferred revenue ......................................................................................  
             Total current liabilities ......................................................................  

Long-term deferred revenue ..........................................................................  

Commitments and contingent liabilities (Note 9) 

Stockholders’ equity: 
     Preferred stock, $1.00 par value; 1,000,000 shares authorized, 
          none outstanding  .................................................................................  
      Common stock, $.01 par value; shares authorized, 
             70,000,000 in 2014 and 2013; issued 
             and outstanding 22,808,761 in 2014 and 22,574,251 in 2013 ..........  
      Additional paid-in capital ........................................................................  
      Accumulated other comprehensive loss ...................................................  
      Accumulated deficit .................................................................................  
             Total stockholders’ equity.................................................................  
             Total liabilities and stockholders’ equity ..........................................  

December 31, 

2014 

2013 

$43,985 

$72,660 

3,619 
2 
168 
401
48,175

5,289 
1,428 
804 
197
$55,893

$258 
108
585
127
2,352 
3,430 

74 

4,582 
  1,601
383
695
79,921

5,582 
2,754 
762 
310
$89,329

$1,516 
108
571
118
1,848 
4,161 

18 

-

-

228 
103,756 
(29)
(51,566)
52,389
$55,893

226
101,293
(125)
(16,244)
85,150
$89,329

The accompanying notes are an integral part of the consolidated financial statements. 

39

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME 
(in thousands, except per share data)

Revenue: 
   Software licenses .............................................................................. 
   Software maintenance ....................................................................... 
   Services ............................................................................................. 
   Hardware  ......................................................................................... 
   Royalties ........................................................................................... 
     Total revenue .................................................................................. 

Costs and expenses: 
   Cost of hardware ............................................................................... 
   Cost of services ................................................................................. 
   Research and development ............................................................... 
   Selling and marketing ....................................................................... 
   General and administrative ............................................................... 
      Total costs and expenses ................................................................ 

Years ended December 31, 

2014 

2013 

2012

$8,537
4,351
5,173
4,933
726
23,720

3,485
2,359
5,505
3,741
3,668
18,758

$8,241 
3,866 
3,148 
3,182 
920 
19,357 

2,365 
1,503 
4,085 
3,344 
3,522 
14,819 

$9,525
3,038
2,571
-
2,170
17,304

-
1,542
3,489
3,370
3,860
12,261

Patent related income ........................................................................... 

2,127

780 

87,515

Operating income  ............................................................................... 
Other income (expense) ....................................................................... 
Interest income .................................................................................... 
Income from continuing operations before income taxes .................... 
Provision for income taxes .................................................................. 
Income from continuing operations  .................................................... 
Loss from discontinued operations, net of income taxes ...................... 
Net income  ........................................................................................... 

Basic net income per share: 
  Basic net income per share from continuing operations .......................
  Basic net loss per share from discontinued operations .........................
Basic net income per share ...............................................................

Diluted net income per share: 
  Diluted net income per share from continuing operations ....................
  Diluted net loss per share from discontinued operations ......................
Diluted net income per share ............................................................

7,089
(59)
225
7,255
2,672
4,583
-
$4,583

$0.20 
- 
$0.20 

$0.20 
- 
$0.20 

5,318 
23 
328 
5,669 
1,917 
3,752 
(1,156) 
$2,596 

$0.17 
(0.05) 
$0.12 

$0.16 
(0.05) 
$0.11 

92,558
85
227
92,870
20,487
72,383
(76)
$72,307

$3.32
(0.00)
$3.32 

$3.28
(0.00)
$3.28

Weighted-average shares - basic .............................................................
Weighted-average shares - diluted ..........................................................

22,703 
22,787 

22,543 
22,641 

21,814 
22,071 

Comprehensive income: 
  Net income ............................................................................................
  Other comprehensive income (net of tax): 
     Unrealized gain/(loss) on available for sale securities .......................
Comprehensive income ..........................................................................

$4,583 

$2,596 

$72,307 

96 
$4,679 

(75) 
$2,521 

(30) 
$72,277 

The accompanying notes are an integral part of the consolidated financial statements. 

40

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
CONSOLIDATED STATEMENTS OF CASH FLOWS 
(in thousands)

Cash flows from operating activities: 
   Net income  .......................................................................... 
   Adjustments to reconcile net income to net cash    
   provided by (used in) operating activities: 
      Depreciation and amortization ........................................... 
      Stock-based compensation ................................................ 
      Gain on sale of patent assets .............................................. 
      Amortization of premium (discount) on investments ........ 
      (Gain)/loss on sale of investments  .................................... 
      Deferred tax benefit (expense) on other comprehensive  
        income  ............................................................................ 
      Loss on disposal of property and equipment  .................... 
      Provision for doubtful accounts  ........................................ 
      Increase (decrease) from changes in assets and liabilities: 
Accounts receivable ........................................................ 
Receivable from patent arrangement .............................. 
Inventories ...................................................................... 
Prepaid expenses and other current assets ...................... 
Deferred tax assets .......................................................... 
Accounts payable ............................................................ 
Accrued expenses, compensation and professional ........ 
Deferred revenue ............................................................ 
           Net cash provided by (used in) operating activities ...... 

Cash flows from investing activities: 
    Purchases of property and equipment .................................. 
    Proceeds from sale of property and equipment ................... 
    Purchases of investments ..................................................... 
    Sales of investments ............................................................ 
    Proceeds from sale of patent assets, net  .............................. 
    Purchase of other assets ....................................................... 
           Net cash provided by (used in) investing activities ...... 

Cash flows from financing activities: 
    Proceeds from issuance of common stock  .......................... 
    Payment of dividends  ......................................................... 
    Excess tax benefits from stock-based compensation ........... 
    Payments made for taxes of employees who surrendered  
      shares related to unrestricted stock  ................................... 
    Repurchase of common stock  ............................................. 
           Net cash provided by (used in) financing activities ...... 

Increase/(decrease) in cash and cash equivalents .................... 
Cash and cash equivalents, beginning of year ......................... 

Years ended December 31, 
2014

2013 

2012

$4,583

$2,596 

$72,307

541
915
(2,127)
(3)
59

(66)
-
-

963
-
1,599
294
173
(1,258)
23
560
6,256

(135)
-
-
1,432
2,127
-
3,424

508
(39,905)
1,247

(205)
-
(38,355)

(28,675)
72,660

458 
662 
- 
15 
(23) 

81 
28 
- 

(1,125) 
1,121 
(1,601) 
(167) 
563 
1,188 
(310) 
(657) 
2,829 

(160) 
24 
(2,008) 
1,117 
- 
(338) 
(1,365) 

65 
- 
128 

(71) 
- 
122 

1,586 
71,074 

453
321
(86,394)
(18)
(85)

-
-
4

85
(1,121)
547
(315)
(1,760)
(71)
9
744
(15,294)

(116)
-
(2,065)
855
86,394
-
85,068

6,526
(66,024)
14,395

(174)
-
(45,277)

24,497
46,577

Cash and cash equivalents, end of year  .................................. 

$43,985

$72,660 

$71,074

Supplemental disclosure: 
    Cash paid for income taxes 

$1,018

$542 

$7,954

The accompanying notes are an integral part of the consolidated financial statements. 

41

 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY 
(in thousands)

Common Stock 
Shares 

Amount 

Additional 
Paid-In 
Capital 

Accumulated 
Other
Comprehensive 
Loss 

(Accumulated 
Deficit) 

Total
Stockholders’ 
Equity 

Balance at December 31, 2011 ..........................

20,623 

$206 

$79,512 

($20) 

($25,123) 

$54,575 

   Exercise of common stock options .................
   Issuance of unrestricted stock .........................
   Shares surrendered by employees to    
      pay taxes related to unrestricted stock .........
   Issuance of common stock under   
       employee stock purchase plan .....................
   Stock-based compensation expense ................
   Tax benefits from stock-based awards ............
   Dividend payment ...........................................
   Accumulated other comprehensive loss: 
      Unrealized loss on securities ........................
   Net income ......................................................

1,764 
151 

(33)

5

18 
1 

-

-

6,481 
(1) 

(174)

27
321 
14,395 

6,499 
- 

(174)

27
321 
14,395 
(66,024) 

(30) 
72,307 

(30) 

(66,024) 

72,307 

Balance at December 31, 2012 ..........................

22,510 

225 

100,561 

(50) 

(18,840) 

81,896 

   Exercise of common stock options .................
   Issuance of unrestricted stock .........................
   Shares surrendered by employees to    
      pay taxes related to unrestricted stock .........
   Issuance of common stock under   
       employee stock purchase plan .....................
   Stock-based compensation expense ................
   Tax benefits from stock-based awards ............
   Deferred tax asset write-off ............................
   Accumulated other comprehensive loss: 
       Unrealized loss on securities .......................
       Deferred tax benefit on unrealized loss .......
   Net income ......................................................

6 
65 

(14)

7

- 
1 

-

-

26 
(1) 

(71)

40
662 
128 
(52) 

(156) 
81 

2,596 

26 
- 

(71)

40
662 
128 
(52) 

(156) 
81 
2,596 

Balance at December 31, 2013 ..........................

22,574 

226 

101,293 

(125) 

(16,244) 

85,150 

   Exercise of common stock options .................
   Issuance of unrestricted stock .........................
   Shares surrendered by employees to    
      pay taxes related to unrestricted stock .........
   Issuance of common stock under   
       employee stock purchase plan .....................  
   Stock-based compensation expense ................
   Tax benefits from stock-based awards ............
   Dividend payment ...........................................
   Accumulated other comprehensive loss: 
       Unrealized gain on securities ......................
       Deferred tax expense on unrealized gain ....
   Net income ......................................................

118 
141 

(32)

8 

1 
1 

-

-

468 
(1) 

(205)

39
915 
1,247 

469 
- 

(205)

39
915 
1,247 
(39,905) 

162 
(66) 
4,583 

162 
(66) 

(39,905) 

4,583 

Balance at December 31, 2014 ..........................

22,809 

$228 

$103,756 

($29) 

($51,566) 

$52,389 

The accompanying notes are an integral part of the consolidated financial statements. 

42

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.  NATURE OF BUSINESS

We are a leading provider of software and services to the biometrics industry.  Our software products are used 
in  government  and  commercial  biometrics  systems,  which  are  capable  of  determining  or  verifying  an 
individual’s  identity.  We  also  offer  engineering  services  related  to  software  customization,  integration,  and 
installation, as well as complete systems development. We sell our biometrics software products and services 
globally through systems integrators, OEMs, and directly to end user customers 

2.      SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  

Basis  of  Presentation  -  The  consolidated  financial  statements  include  the  accounts  of  Aware,  Inc.  and  its 
subsidiary (“the Company”).  All significant intercompany transactions have been eliminated.   

Use  of  Estimates  – The  preparation  of  our  financial  statements  in  conformity  with  accounting  principles 
generally accepted in the United States of America requires us to make estimates and assumptions that affect 
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of 
the financial statements and the reported amount of revenues and expenses during the reporting period.  The 
most  significant  estimates  included  in  the  financial  statements  pertain  to  revenue  recognition,  reserves  for 
doubtful accounts, useful lives of fixed assets, valuation allowance for deferred income tax assets, and accrued 
liabilities.  Actual results could differ from those estimates. 

Fair Value Measurements - The Financial Accounting Standards Board (“FASB”) Codification defines fair 
value, and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure 
fair  value.  The  hierarchy  gives  the  highest  priority  to  the  unadjusted  quoted  prices  in  active  markets  for 
identical  assets  or  liabilities  (level  1  measurements)  and  the  lowest  priority  to  unobservable  inputs  (level  3 
measurements).  The  three  levels  of  the  fair  value  hierarchy  under  the  FASB  Codification  are:  i)  Level  1  – 
valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that 
the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on 
quoted prices in markets that are not active or for which all significant inputs are observable, either directly or 
indirectly;  and  iii)  Level  3  –  valuations  that  require  inputs  that  are  both  significant  to  the  fair  value 
measurement and unobservable. 

Cash and cash equivalents, which primarily include money market mutual funds, were $44.0 million and $72.7 
million as of December 31, 2014 and December 31, 2013, respectively. We classified our cash equivalents of 
$34.3 million and $68.6 million as of December 31, 2014 and 2013, respectively, within Level 1 of the fair 
value hierarchy because they are valued using quoted market prices. 

Our investments, which consist of high yield corporate debt securities, are also classified within Level 1 of the 
fair  value  hierarchy  because  they  are  valued  using  quoted  market  prices.  Debt  securities  with  maturities 
greater  than  one  year  are  classified  as  long  term  assets.  We  categorize  our  investments  as  available-for-sale 
securities, and carry them at fair value in our financial statements.  We had $1.4 million and $2.8 million of 
available-for-sale investments as of December 31, 2014 and December 31, 2013, respectively. 

As of December 31, 2014, our assets that are measured at fair value on a recurring basis and whose carrying 
values approximate their respective fair values include the following (in thousands): 

Fair Value Measurement at December 31, 2014 Using: 

Quoted Prices in 
Active Markets for 
Identical Assets 
(Level 1) 

Significant Other 
Observable Inputs 
(Level 2) 

Significant 
Unobservable 
Inputs 
(Level 3) 

Corporate debt securities .............
Money market funds (included 
in cash and cash equivalents) ......
    Total ........................................

$1,428 

34,339 
$35,767 

43

$- 

$- 

$- 

$- 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

As of December 31, 2013, our assets that are measured at fair value on a recurring basis and whose carrying 
values approximate their respective fair values include the following (in thousands): 

Fair Value Measurement at December 31, 2013 Using: 

Quoted Prices in 
Active Markets for 
Identical Assets 
(Level 1) 

Significant Other 
Observable Inputs 
(Level 2) 

Significant 
Unobservable 
Inputs 
(Level 3) 

Corporate debt securities .............
Money market funds (included 
in cash and cash equivalents) ......
    Total ........................................

$2,754 

68,556 
$71,310 

$- 

$- 

$- 

$- 

Cash and Cash Equivalents – Cash and cash equivalents, which consist primarily of money market funds and 
demand deposits, are stated at fair value. All highly liquid investments purchased with an original maturity of 
three months or less are considered cash equivalents. Our cash balances exceed the Federal Deposit Insurance 
Corporation limits. The Company does not believe it is exposed to significant credit risk related to cash and 
cash equivalents. 

Investments - At December 31, 2014 and 2013, we categorized all investment securities as available-for-sale, 
since  we  may  liquidate  these  investments  currently.    In  calculating  realized  gains  and  losses,  cost  is 
determined  using  specific  identification.  Unrealized  gains  and  losses  on  available-for-sale  securities  are 
excluded  from  earnings  and  reported  in  a  separate  component  of  stockholders’  equity  called  Accumulated 
Comprehensive Income. 

Realized  losses  on  investments  were  $59,000  in  the  year  ended  December  31,  2014.  Realized  gains  on 
investments were $23,000 and $85,000 in the years ended December 31, 2013 and 2012, respectively.   

Unrealized gains on investments were $162,000 in the year ended December 31, 2014. Unrealized losses on 
investments were $156,000, and $30,000 in the years ended December 31, 2013, and 2012.   

The amortized cost of our corporate debt securities was $1.5 million at December 31, 2014. Corporate debt 
securities comprising investments mature in 2017 and 2018.  

Allowance for Doubtful Accounts – Accounts are charged to the allowance for doubtful accounts as they are 
deemed uncollectible based on a periodic review of the accounts.   

Inventories – Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-
in, first-out (“FIFO”) method.  We evaluate all inventories for net realizable value on a quarterly basis, and 
record  provisions  for  excess  and  obsolete  inventory  when  required.    There  was  no  reserve  for  excess  and 
obsolete inventory as of December 31, 2014. 

Property  and  Equipment  –  Property  and  equipment  is  stated  at  cost.    Depreciation  and  amortization  of 
property and equipment is provided using the straight-line method over the estimated useful lives of the assets. 
Upon  retirement  or  sale,  the  costs  of  the  assets  disposed  of  and  the  related  accumulated  depreciation  are 
removed  from  the  accounts  and  any  resulting  gain  or  loss  on  disposal  is  included  in  the  determination  of 
income or loss.  Expenditures for repairs and maintenance are charged to expense as incurred. 

The estimated useful lives of assets used by us are: 

Building ...............................................................................   30 years 
Building improvements ........................................................   5 to 20 years 
Furniture and fixtures ...........................................................   5 years 
Computer, office & manufacturing equipment ....................   3 years 
Purchased software ..............................................................   3 years 

Impairment of Long-Lived Assets – We review long-lived assets for impairment whenever events or changes 
in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that 

44

 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

the useful lives of these assets are no longer appropriate.  Each impairment test is based on a comparison of 
the undiscounted cash flows estimated to be generated by those assets over their estimated economic life to the 
related carrying value of those assets to determine if the assets are impaired. If an impairment is indicated, the 
asset  is  written  down  to  its  estimated  fair  value.    The  cash  flow  estimates  used  to  identify  the  potential 
impairment reflect our best estimates using appropriate assumptions and projections at that time.  We believe 
that no significant impairment of our long-lived assets has occurred as of December 31, 2014 and 2013. 

Revenue Recognition – We recognize revenue when there is persuasive evidence of an arrangement, the sales 
price  is  fixed  or  determinable,  collection  of  the  related  receivable  is  reasonably  assured,  and  delivery  has 
occurred or services have been rendered. 

Persuasive evidence of an arrangement: We use contracts signed by both the customer and us or written 

purchase orders issued by the customer as evidence of an arrangement. 

Product delivery: We deem delivery to have occurred: (i) upon shipment when products are shipped FOB 
shipping point, or (ii) upon delivery at a customer’s location when products are shipped FOB destination, or 
(iii)  when  software  is  delivered  electronically.    If  customer  acceptance  provisions  apply,  revenue  is  not 
recognized until delivery has occurred and we have received such  acceptance. If we are required to provide 
installation services, revenue is not recognized until installation is complete. 

Fixed or determinable fee: We consider fees to be fixed or determinable if the fee is not subject to refund 
or  adjustment  and  the  payment  terms  are  within  normal  established  practices.  If  the  fee  is  not  fixed  or 
determinable, we recognize the revenue as amounts become due and payable. 

Collection is deemed probable: We conduct a credit review for significant transactions at the time of the 
arrangement to determine the credit-worthiness of the customer. Collection is deemed probable if we expect 
that the customer will pay amounts under the arrangement as payments become due. 

We categorize revenue as software licenses, software maintenance, services, hardware, or royalties. In addition 
to  the  general  revenue  recognition  policies  described  above,  specific  revenue  recognition  policies  apply  to 
each category of revenue.   

Software licenses
Software  licenses  consist  of  revenue  from  the  sale  of  software  licenses  for  biometrics  and  imaging 
applications.    Our  software  licenses  typically  provide  customers  with  the  right  to  use  our  software  in 
perpetuity.    We  recognize  revenue  from  software  licenses  upon  delivery  when  licenses  are  sold  in  single 
element  arrangements,  because  we  have  no  post-delivery  obligations,  including  contractual  or  implied  Post 
Contract Support (“PCS”). 

Software maintenance
Software maintenance consists of revenue from the sale of software maintenance contracts for biometrics and 
imaging software.  Software maintenance contracts entitle customers to receive software support and software 
updates,  if  and  when  they  become  available,  during  the  term  of  the  maintenance  contract.  We  recognize 
software maintenance revenue ratably over the related contract period. 

Services
Service revenue consists of fees from biometrics customers for software engineering services we provide to 
them.  We  recognize  services  revenue  as  services  are  delivered  when  services  are  sold  in  single  element 
arrangements. 

Hardware 
Hardware  revenue  consists  of  sales  of  biometrics  equipment  to  a  single  U.S.  government  customer.    We 
recognize hardware revenue upon delivery and acceptance of the equipment by the customer. 

45

AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Royalties
Royalties consist primarily of royalty payments we receive under DSL silicon contracts with two customers 
that incorporate our silicon intellectual property (“IP”) in their DSL chipsets.  We sold the assets of our DSL 
IP business in 2009, but we continue to receive royalty payments from these customers.  Royalties are reported 
in continuing operations in accordance with ASC 205, Reporting Discontinued Operations, because we have 
continuing ongoing cash flows from this business. 

Since  we  cannot  reasonably  estimate  royalty  revenue,  such  revenue  is  recognized  in  the  quarter  in  which  a 
final  report  is  received  from  a  customer.  Royalty  reports  are  typically  received  in  the  quarter  immediately 
following the quarter in which sales of royalty-bearing products occur. 

Multiple element arrangements with software and software related elements 
In  addition  to  selling  software  licenses,  software  maintenance  and  software  services  in  single  element 
arrangements,  we  also  sell  these  three  products  as  part  of  multiple  element  arrangements.    We  apply  the 
provisions of ASC 985-605, Software Revenue Recognition, to these arrangements because all the elements 
are software or software related.  The various combinations of multiple element arrangements and our revenue 
recognition for each are described as follows: 

(cid:120)

(cid:120)

(cid:120)

Software  licenses  and  software  maintenance.  When  software  licenses  and  software  maintenance 
contracts are sold together, we recognize software license revenue upon delivery, provided we have 
vendor specific objective evidence (“VSOE”) for the fair value of the maintenance contract fee, and 
we recognize the fair value of maintenance contract revenue ratably over the related contract period. 
Under ASC 985-605, the residual method is the appropriate manner in which to allocate arrangement 
consideration to the license when VSOE exists for all undelivered elements (e.g., PCS), but not for 
the delivered element (e.g., the license). 

Software  licenses  and  services.  When  software  licenses  and  software  engineering  services  are  sold 
together, the total fee is generally recognized by applying contract accounting. We have adopted the 
percentage-of-completion method of contract accounting, and we generally use an input method (i.e., 
labor hours) to determine our completion percentage. The software license portion of the arrangement 
is classified as software license revenue and the engineering services portion is classified as services 
revenue in our consolidated statements of income and comprehensive income. 

Software  licenses,  software  maintenance  and  services.  When  we  sell  software  licenses,  software 
maintenance  and  software  services  together,  revenue  is  recognized  as  follows:  i)  software 
maintenance  revenue  is  separated  from  the  other  two  elements  and  is  recognized  ratably  over  the 
related  software  maintenance  contract  period;  provided  we  have  VSOE  for  the  fair  value  of  the 
maintenance element; and ii) the total fee from the software license and engineering service elements 
is recognized by applying the contract accounting method described in the previous paragraph.  

Multiple element arrangement with hardware and software elements 
We  also  have  a  multiple  element  arrangement  with  one  customer  that  involves  the  delivery  of  hardware, 
software maintenance, and software services.  We determined that these elements qualified as separate units of 
accounting under ASC 605, Revenue Recognition, because they have value to the customer on a standalone 
basis.    We  recognize  revenue  from  this  arrangement  as  follows:  i)  hardware  revenue  is  recognized  upon 
delivery and acceptance of the equipment by the customer; ii) maintenance revenue is recognized ratably over 
the related contract period; and iii) service revenue is recognized as services are delivered. 

Income Taxes – We compute deferred income taxes based on the differences between the financial statement 
and  tax  basis  of  assets  and  liabilities  using  enacted  rates  in  effect  in  the  years  in  which  the  differences  are 
expected  to  reverse.    We  establish  a  valuation  allowance  to  offset  temporary  deductible  differences,  net 
operating loss carryforwards and tax credits when it is more likely than not that the deferred tax assets will not 
be realized. 

We  recognize  the  tax  benefit  from  an  uncertain  tax  position  only  if  it  is  more-likely-than-not  that  the  tax 
position will be sustained upon examination by the taxing authorities, based on the technical merits of the tax 
position. The evaluation of an uncertain tax position is based on factors that include, but are not limited to, 

46

AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

changes  in  the  tax  law,  the  measurement  of  tax  positions  taken  or  expected  to  be  taken  in  tax  returns,  the 
effective settlement of matters subject to audit, and changes in facts or circumstances related to a tax position.  
Any  changes  to  these  estimates,  based  on  the  actual  results  obtained  and/or  a  change  in  assumptions,  could 
impact our tax provision in future periods.  Interest and penalty charges, if any, related to unrecognized tax 
benefits would be classified as a provision for income tax in the statement of income. 

Capitalization  of  Software  Costs  –  We  capitalize  certain  internally  developed  software  development  costs 
after technological feasibility of the product has been established.  No software costs were capitalized for the 
years ended December 31, 2014, 2013 and 2012, because such costs incurred subsequent to the establishment 
of technological feasibility, but prior to commercial availability, were immaterial. 

Research  and  Development  Costs  –  Costs  incurred  in  the  research  and  development  of  our  products  are 
expensed as incurred. 

Concentration of Credit Risk – At December 31, 2014 and 2013, we had cash and cash equivalents, in excess 
of federally insured deposit limits of approximately $43.7 million and $72.4 million, respectively. 

Concentration  of  credit  risk  with  respect  to  net  accounts  receivable  consisted  of  amounts  owed  by  the 
following customers that comprised more than 10% of net accounts receivable at December 31: 

Customer A   ...................................................  
Customer B   ...................................................  
Customer C   ...................................................  

18% 
15% 
11% 

60% 
-% 
-% 

2014 

2013 

Concentration of credit risk with respect to our investment portfolio consisted of $0.5 million, $0.5 million, 
and $0.4 million with three issuers of corporate debt securities, respectively, at December 31, 2014, and $0.8 
million, $0.5 million, $0.5 million, $0.5 million, and $0.4 million with five issuers of corporate debt securities, 
respectively, at December 31, 2013.  

Stock-Based Compensation – We grant stock and stock options to our employees and directors.  We measure 
stock-based compensation cost at the grant date based on the fair value of the award and recognize stock-based 
compensation expense on a straight-line basis over the requisite service period of the award.  

For stock awards, we determine the fair value of the award by using the fair market value of our stock on the 
date of grant; provided the number of shares in the grant is fixed on the grant date. 

For stock options, we use the Black-Scholes option valuation model to estimate the fair value of the award. 
This  valuation  model  takes  into  account  the  exercise  price  of  the  award,  as  well  as  a  variety  of  significant 
assumptions.  The assumptions used to estimate the fair value of stock options include the expected term, the 
expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and 
our expected annual dividend yield.   

Computation of Earnings per Share – Basic earnings per share is computed by dividing income available to 
common shareholders by the weighted average number of common shares outstanding.  Diluted earnings per 
share is computed by dividing income available to common shareholders by the weighted average number of 
common  shares  outstanding  plus  additional  common  shares  that  would  have  been  outstanding  if  dilutive 
potential common shares had been issued.  For the purposes of this calculation, stock options are considered 
common stock equivalents in periods in which they have a dilutive effect.  Stock options that are antidilutive 
are excluded from the calculation. 

Fair  Value  of  Financial  Instruments  –  The  carrying  amounts  of  cash  and  cash  equivalents,  accounts 
receivable, accounts payable and accrued expenses approximate fair value because of their short-term nature. 
The carrying amount of investments is based on the fair value of the individual securities in our investment 
portfolio.

47

 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Advertising  Costs  –  Advertising  costs  are  expensed  as  incurred  and  were  not  material  for  2014,  2013,  and 
2012. 

Recent  Accounting  Pronouncements  –  In  May  2014,  the  FASB  issued  ASU  2014-09,  Revenue  from 
Contracts  with  Customers  (Topic  606).  The  ASU  is  the  result  of  a  joint  project  by  the  FASB  and  the 
International  Accounting  Standards  Board  (“IASB”)  to  clarify  the  principles  for  recognizing  revenue  and  to 
develop a common revenue standard for GAAP and International Financial Reporting Standards (“IFRS”) that 
would:  remove  inconsistencies  and  weaknesses,  provide  a  more  robust  framework  for  addressing  revenue 
issues,  improve  comparability  of  revenue  recognition  practices  across  entities,  jurisdictions,  industries,  and 
capital  markets,  improve  disclosure  requirements  and  resulting  financial  statements,  and  simplify  the 
presentation of financial statements. The core principle of the new guidance is that an entity should recognize 
revenue  to  depict  the  transfer  of  promised  goods  or  services  to  customers  in  an  amount  that  reflects  the 
consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU is 
effective for annual reporting periods beginning after December 15, 2016.  Early adoption is not permitted. We 
are currently evaluating the effect that the updated standard will have on our consolidated financial statements 
and related disclosures. 

With  the  exception  of  the  new  revenue  standard  discussed  above,  there  have  been  no  other  recently  issued 
accounting pronouncements that are of significance or potential significance to us that we have not adopted as 
of December 31, 2014. 

Reclassifications - Certain prior period amounts have been reclassified to be consistent with the current period 
presentation. 

Segments – We organize ourselves into a single segment reporting to the chief operating decision makers. We 
have sales outside of the United States, which are described in Note 10.  All long-lived assets are maintained in 
the United States. 

3. PATENT RELATED INCOME 

Patent related income in the years ended December 31, 2014, 2013 and 2012 was derived from either gains on 
the sale of patent assets or income from a patent arrangement, or both. Income from these sources was included 
in income from continuing operations pursuant to ASC 360-10, Impairment or Disposal of Long-Lived Assets, 
and Rule 5-03 of Regulation S-X. 

The composition of patent related income in 2014, 2013, and 2012 was as follows: 

Year ended December 31, 2014. We had a $2.1 million gain on the sale of patent assets and no income from our 
patent arrangement in 2014. The gain on the sale of patent assets is described below: 

We sold a portion of our patent portfolio pertaining to DSL diagnostic technology to an unrelated third party 
for  $2.6  million.  The  proceeds  from  the  sale  were  reduced  by  $0.5  million  of  transaction  costs,  which 
consisted primarily of fees from the law firm that assisted us in the sale.  We recorded a gain of $2.1 million 
on the sale. 

The DSL diagnostic technology in the patents we sold in 2014 was related to our DSL Service Assurance 
business that we shut down in 2012 and 2013 and reported in discontinued operations in those periods. We 
do  not  consider  our  patent  related  activities  to  be  a  component  of  the  operating  business  from  which  the 
underlying  technology  was  derived,  but  rather  as  a  component  of  corporate  general  and  administrative 
expenses.    Accordingly  the  gain  on  the  sale  of  these  patents  was  reported  in  income  from  continuing 
operations.   

Year ended December 31, 2013. We had $0.8 million of income from a patent arrangement and no gains on the 
sale of patent assets in 2013.  Income from the patent arrangement is described below: 

48

AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

We  entered  into  an  arrangement  with  an  unaffiliated  third  party  in  2010  under  which  we  assigned  certain 
patents  in return  for  royalties  on proceeds from  patent  monetization  efforts  by  the  third  party.   Such third 
party has engaged in various patent monetization activities, including enforcement, litigation and licensing. 
The  party  reported  and  we  recorded  $0.8  million  of  income  from  this  arrangement  in  the  year  ended 
December 31, 2013. 

We continue to have a contractual relationship with this third party. However, we are unable to predict how 
much more income we might receive from this arrangement, if any, because:  

(cid:120)

The  claims  in  one  of  the  patents  we  assigned  were  rejected  by  the  United  States  Patent  Office 
(“USPTO”) in May 2013. The USPTO’s Patent Trial & Appeal Board (“PTAB”) affirmed the USPTO 
decision in June 2014.  The PTAB decision was appealed to the Federal Circuit.  In December 2014, 
the Federal Circuit remanded the appeal back to the PTAB for further consideration. 

(cid:120) Notwithstanding the outcome at the PTAB, we do not know whether any patent monetization efforts 

by the third party will be successful. 

Year ended December 31, 2012. We had total patent related income of $87.5 million in 2012, which consisted 
of $86.4 million of gains on the sale of patent assets and $1.1 million of income from our patent arrangement. 
Patent related income in 2012 is described below: 

Gains on the sale of patent assets. Total gains on the sale of patent assets in 2012 were $86.4 million, which 
consisted of gains from two separate sales.  Gains from both sales were recorded in income from continuing 
operations as none of these patents were related to any discontinued operations, including our discontinued 
DSL Service Assurance business.  The two sales are described below: 

(cid:120) We sold a portion of our patent portfolio pertaining to wireless technology to an unaffiliated third 
party  for  $75.0  million.  The  proceeds  from  the  sale  were  reduced  by  $3.8  million  of  transaction 
costs, which consisted primarily of fees from the law firm that assisted us in the sale.  We recorded a 
gain of $71.2 million on the sale. 

(cid:120) We  sold  a  portion  of  our  patent  portfolio  pertaining  to  DSL  semiconductor  intellectual  property 
technology  for  $16.0  million.  The  proceeds  from  the  sale  were  reduced  by  $0.8  million  of 
transaction costs, which also consisted primarily of fees from the law firm that assisted us in the sale.  
We recorded a gain of $15.2 million on the sale. 

Income from patent arrangement.  The third party to whom we assigned patents reported and we recorded 
$1.1 million of income from this arrangement in the year ended December 31, 2012.

4.   DISCONTINUED OPERATIONS 

Our  board  of  directors  approved  the  shutdown  of  our  DSL  service  assurance  hardware  and  software  product 
lines  in  2012  and  2013,  respectively.  Both  product  lines  were  previously  components  of  our  DSL  Service 
Assurance  Segment.  Results  from  the  DSL  Service  Assurance  Segment  have  been  reported  as  discontinued 
operations  because  we  no  longer  have  any  significant  continuing  involvement  with,  or  cash  flows  from,  this 
segment. 

Loss from the discontinued DSL Service Assurance Segment was (in thousands): 

Years ended December 31, 
2013 

2014 

2012 

  Revenue .......................................................................
  Expenses .....................................................................
     Loss before income taxes .........................................
  Income tax benefit  ......................................................
     Loss from discontinued operations ..........................

$- 
- 
- 
- 
$- 

$3,216 
5,120 
(1,904) 
(748) 
($1,156) 

$5,431 
5,558 
(127) 
(51) 
($76) 

49

 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

The consolidated statements of income and comprehensive income for the year ended December 31, 2012 was 
reclassified to reflect the effect of discontinued operations as set forth above. 

We  incurred  one-time  costs  related  to  the  shutdown  of  the  DSL  service  assurance  hardware  and  software 
product lines.  Shutdown costs for each product line were: 

DSL service assurance hardware product line.  In 2012, we incurred one-time shutdown costs related to the 
hardware product line of approximately $0.3 million, the majority of which were severance and employee-
related costs.  All such costs were incurred, paid, and included in loss from discontinued operations for the 
year ended December 31, 2012.  

DSL service assurance software product line.  In 2013, we incurred one-time shutdown costs related to the 
software product line of approximately $2.9 million. Such costs comprise: i) $3.7 million of payments to 
customers  to  terminate  contracts,  which  were  offset  by  $1.2  million  of  deferred  revenue  obligations  that 
were relieved as a result of such contract terminations; ii) $0.3 million of severance and employee-related 
costs;  and  iii)  $48,000  of  asset  write-offs.    All  such  costs  were  incurred  and  included  in  loss  from 
discontinued  operations  for  the  year  ended  December  31,  2013.  All  DSL  service  assurance  software 
product line exit costs were paid in 2013, with the exception of $0.1 million of severance costs, which were 
paid in early January 2014. 

There were no assets or liabilities remaining on the balance sheet as of December 31, 2014 related to the DSL 
Service Assurance Segment.  

5.

INVENTORIES 

Inventories consisted of the following at December 31 (in thousands): 

 Raw materials ..............................................  
 Finished goods.............................................  
     Total ........................................................  

2014 

$2 
- 
$2 

2013 

$1,584 
17 
$1,601 

6.     PROPERTY AND EQUIPMENT 

        Property and equipment consisted of the following at December 31 (in thousands): 

2014 

2013 

Land .....................................................................................  
Building and improvements .................................................  
Computer equipment ............................................................  
Purchased software ..............................................................  
Furniture and fixtures ...........................................................  
Office equipment .................................................................  
   Total ..................................................................................  
Less accumulated depreciation and amortization .................  
   Property and equipment, net .............................................  

$1,056
9,060
614
78
778
191
11,777
(6,488)
$5,289

$1,056
9,060
557
88
778
191
11,730
(6,148)
$5,582

Depreciation expense was $0.4 million, $0.5 million, and $0.4 million for the years ended December 31, 
2014, 2013, and 2012, respectively.  In 2014, 2013 and 2012, we identified $0.1 million, $0.3 million, and 
$1.0 million of assets no longer in use and retired the assets and related accumulated depreciation.  

50

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

7.      INCOME TAXES 

We made provisions for income taxes related to continuing operations in the years ended December 31, 2014, 
2013 and 2012 of $2.7 million, $1.9 million and $20.5 million, respectively. The components of the provision 
for income taxes are as follows (in thousands): 

Current: 
    Federal  ...........................................
    State ................................................

Deferred: 
    Federal  ...........................................
    State ................................................

Year ended December 31, 
2013 

2012 

2014 

$1,976 
589 
2,565 

93 
14 
107 

$1,000 
273 
1,273 

471 
173 
644 

$20,654 
1,594 
22,248 

(1,354) 
(407) 
(1,761) 

Total provision for income taxes ........

$2,672 

$1,917 

$20,487 

A reconciliation of the U.S. federal statutory rate to the effective tax rate is as follows: 

Federal statutory rate .............................................................  
State rate, net of federal benefit .............................................  
Tax credits .............................................................................  
Permanent adjustments  .........................................................  
Change in valuation allowance ..............................................  
Prior year adjustment  ............................................................  
   Effective tax rate .................................................................  

Year ended December 31, 
2013 
    34% 
5 
(2) 
(1) 
- 
(2) 
34% 

2014 
    34% 
5 
(1) 
(1) 
- 
- 
37% 

2012 
   35% 
5 
- 
- 
(18) 
- 
22% 

Total income tax expense for the year ended December 31, 2014 was $2.7 million, all of which was included 
in continuing operations. Income tax expense for 2014 was based on the U.S. statutory rate of 34%, increased 
by state income taxes, and reduced by Federal research tax credits and permanent adjustments. 

Total income tax expense for the year ended December 31, 2013 was $1.2 million, including $1.9 million of 
tax expense that was recorded in continuing operations less a tax benefit of $0.7 million that was recorded in 
discontinued operations. Income tax expense for 2013 was based on the U.S. statutory rate of 34%, increased 
by state income taxes, and reduced by Federal research tax credits and permanent adjustments.  Tax expense in 
2013  also  reflects  two  items  related  to  2012,  including:  i)  a  tax  benefit  of  $0.1  million  related  to  the  2012 
research tax credit. This credit was extended retroactively back to January 1, 2012, by the American Taxpayer 
Relief Act of 2012, which was enacted on January 2, 2013; and ii) a tax benefit of $0.1 million related to a 
reduction in the estimate of the 2012 tax expense recorded in our 2012 financial statements. 

Total income tax expense for the year ended December 31, 2012 was $20.4 million, including $20.5 million of 
tax  expense  that  was  recorded  in  continuing  operations  less  a  tax  benefit  of  $51,000  that  was  recorded  in 
discontinued operations. Our actual tax liability for 2012 was $7.8 million as taxes that were currently payable 
were reduced by a $14.4 million equity adjustment. This equity adjustment is described more fully below.  

In 2012, we used a significant portion of our available deferred tax assets to reduce income taxes on pre-tax 
income. A substantial portion of the deferred tax assets we utilized comprised cumulative deductions for stock 
options in excess of book expense. Under income tax accounting rules, the portion of tax benefits attributable 
to such deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. In 
the year ended December 31, 2012, the tax benefits from such stock-based awards were $14.4 million, which 
we recorded as an equity adjustment to additional paid-in capital. 

51

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Income  tax  expense  in  2012  was  also  reduced  by  a  $1.8  million  reversal  of  the  valuation  allowance  on  our 
remaining deferred tax assets at December 31, 2012. We reversed the valuation allowance because based on all 
the available evidence, we believed that it is more likely than not that our deferred tax assets will be realizable.  
In reaching this determination, we evaluated: i) our most recent years operating results; ii) our future financial 
plans; and iii) the nature of the components comprising deferred tax assets at December 31, 2012. 

As  of  December  31,  2014  and  2013,  we  had  deferred  tax  assets  for  which  we  had  recorded  no  valuation 
allowance.  The principal components of deferred tax assets were as follows at December 31 (in thousands): 

Depreciation ...................................................................................  
Stock compensation  .......................................................................  
Capitalized research and development costs  .................................  
Other  ..............................................................................................  
   Total.............................................................................................  
Less valuation allowance ................................................................  
   Deferred tax assets, net ................................................................  

2014 

$374 
303 
96 
199 
972 
(-) 
$ 972  

2013 

$418 
199 
364 
164 
1,145 
(-) 
$ 1,145  

We  will  continue  to  assess  the  level  of  valuation  allowance  required  in  future  periods.  Should  evidence 
regarding  the  realizability  of  tax  assets  change  at  a  future  point  in  time,  the  valuation  allowance  will  be 
adjusted accordingly.  

As  a  result  of  significant  taxable  income  in  2012  and  the  utilization  of  research  and  development  credits 
thereon,  we  conducted  a  review  to  determine  whether  any  of  our  prior  year  research  and  development  tax 
credits represented an uncertain tax position.  Based on that review, we determined that $1.9 million of federal 
credits and $1.0 million of state credits could not be supported and therefore, those credits were written off.  In 
addition  to  the  write-off,  we  also  determined  that  $1.9  million  of  federal  credits  and  $1.0  million  of  state 
credits represented an uncertain tax position for which we established a valuation allowance.  A rollforward of 
the uncertain tax position related to our research and development tax credits is as follows (in thousands): 

Uncertain tax positions at December 31, 2011 .....  
Increase due to positions taken in prior periods  ..  
Uncertain tax positions at December 31, 2012 ..... 
Increase due to positions taken in prior periods  ..  
Uncertain tax positions at December 31, 2013 ..... 
Increase due to positions taken in prior periods  ..  
Uncertain tax positions at December 31, 2014 ..... 

$- 
2,945 
$2,945 
- 
$2,945 
- 
$2,945 

Uncertain  tax  positions  of  $2.6  million  will  impact  our  tax  rate  if  realized.    The  difference  between  this 
amount and the total uncertain tax positions in the table above is the federal tax effect on state tax credits.  

In addition to deferred tax assets carried on our balance sheet, we also had net federal and state research and 
development  credit  carryforwards  available  at  December  31,  2014  of  $4.0  million  and  $0.3  million.    These 
credits were not recorded as tax assets as they relate to excess stock compensation deductions that may not be 
recorded as tax assets under generally accepted accounting principles until the amounts have been utilized to 
reduce  our  tax  liability.  To  the  extent  that  these  assets  are  used  to  reduce  future  taxes,  the  benefit  will  be 
recorded  as  a  reduction  to  additional  paid-in  capital.  In  2014  and  2013,  we  recorded  tax  benefits  of  $1.2 
million and $0.1 million to equity related to the use of these tax credits to reduce our tax liability.

Our policy is to recognize interest and penalties related to uncertain tax positions in income tax expense.  As 
of December 31, 2014, we had no accrued interest or penalties related to uncertain tax positions. 

The tax years from 1999 through 2014 are subject to examination by the IRS and state tax authorities. In the 
third quarter of 2014, the Internal Revenue Service commenced an examination of our tax return for the year 
ended December 31, 2012. 

52

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

8.     EQUITY AND STOCK COMPENSATION PLANS

Fixed  Stock  Option  Plans  –  We  have  two  fixed  option  plans.    Under  our  1996  Stock  Option  Plan  (“1996 
Plan”), we were authorized to grant incentive stock options and nonqualified stock options to our employees 
and directors for up to 6,100,000 shares of common stock. There were no shares available for grant under the 
1996  Plan  as  of  December  31,  2014.    Under  our  2001  Nonqualified  Stock  Plan  (“2001  Plan”),  we  are 
authorized  to  grant  nonqualified  stock  options,  stock  appreciation  rights  and  stock  awards  to  our  employees 
and directors for up to 8,000,000 shares of common stock.  As of December 31, 2014, there were 5,062,381 
shares available for grant under the 2001 Plan. 

Under  both  plans,  options  are  granted  at  exercise  prices  as  determined  by  the  Board  of  Directors  and  have 
terms ranging from four to a maximum of ten years. Our options generally vest over three to five years.  

The  following  table  presents  stock-based  employee  compensation  expenses  included  in  our  consolidated 
statements of income and comprehensive income (in thousands):   

Cost of services 
Research and development 
Selling and marketing 
General and administrative 
Loss from discontinued operations 
   Stock-based compensation expense 

Years ended December 31, 

2014 
$44 
106 
17 
748 
- 
$915 

2013 
$34 
81 
14 
533 
- 
$662 

2012 
$16 
51 
126 
83 
45 
$321 

Stock-based compensation expenses in the preceding table include expenses associated with grants of: i) stock 
options;  and  iii)  unrestricted  shares  of  our  common  stock.    The  method  used  to  determine  stock-based 
compensation expense for each type of equity grant is described in the following paragraphs. 

Stock Option Grants. For the years ended December 31, 2014, 2013, and 2012, we granted stock options for 0, 
0,  and  50,000  shares,  respectively.  We  estimate  the  fair  value  of  stock  options  using  the  Black-Scholes 
valuation model.  

The Black-Scholes valuation model takes into account the exercise price of the award, as well as a variety of 
significant assumptions. The assumptions used to estimate the fair value of stock options include the expected 
term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected 
term,  and  our  expected  annual  dividend  yield.  We  believe  that  the  valuation  technique  and  the  approach 
utilized to develop the underlying assumptions are appropriate in calculating the fair values of stock options 
granted in the year ended December 31, 2012. Estimates of fair value are not intended to predict actual future 
events or the value ultimately realized by persons who receive equity awards. 

We did not grant any stock options in 2014 and 2013.  Specific assumptions used to determine the fair value of 
options granted during the year ended December 31, 2012, using the Black-Scholes valuation model were: 

Expected term (1) 
Expected volatility factor (2) 
Risk-free interest rate (3) 
Expected annual dividend yield 

Year Ended 
December 31, 
2012 
5 years 
58-63% 
         0.92% 
n/a 

(1) The expected term for each grant was determined based on the contractual term of the option.  

(2) The expected volatility for each grant is estimated based on an average of historical volatility over a 
period of time which we believe to be representative of our future volatility. 

53

AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(3) The risk-free interest rate for each grant is based on the U.S. Treasury yield curve in effect at the time 
of grant for a period equal to the expected term of the stock option. 

We do not estimate our forfeiture rates as the actual forfeiture rate is known at the end of each reporting period 
due to the timing of our stock option vesting.   

Unrestricted  Stock  Grants.    Our  2001  Plan  permits  us  to  grant  shares  of  unrestricted  stock  to  our  directors, 
officers and employees.  Stock-based compensation expense for stock grants is determined based on the fair 
market value of our stock on the date of grant; provided the number of shares in the grant is fixed on the grant 
date.   

We granted 152,000, 130,000, and 0 shares of unrestricted stock during the years ended December 31, 2014, 
2013, and 2012, respectively. The accounting treatment of those awards is described below: 

Year  ended  December  31,  2014.  In  March  2014,  we  granted  152,000  shares  of  unrestricted  stock  to 
directors, officers and employees. The shares were issued in two equal installments shortly after June 30, 
2014 and December 31, 2014. We expensed $876,000 of stock-based compensation expense related to this 
grant in the year ended December 31, 2014. There was no unamortized stock-based compensation charge 
associated with this stock grant as of December 31, 2014. 

We  issued  shares  of  common  stock  related  to  the  March  2014  grant  as  follows:  i)  58,769  net  shares  of 
common stock were issued in early July 2014 after employees surrendered 17,231 shares for which we paid 
$113,000 of withholding taxes on their behalf; and ii) 56,804 shares of common stock were issued in early 
January 2015 after employees surrendered 19,196 shares for which we paid $87,000 of withholding taxes 
on their behalf. 

Year ended December 31, 2013. In April 2013, we granted 130,000 shares of unrestricted stock to directors, 
officers and employees. The shares were issued in two equal installments shortly after June 30, 2013 and 
December 31, 2013. We expensed $623,000 of stock-based compensation expense related to this grant in 
the year ended December 31, 2013. There was no unamortized stock-based compensation charge associated 
with this stock grant as of December 31, 2013.  

We  issued  shares  of  common  stock  related  to  the  April  2013  grant  as  follows:  i)  51,374  net  shares  of 
common stock were issued in early July 2013 after employees surrendered 13,626 shares for which we paid 
$71,000  of  withholding  taxes  on  their  behalf;  and  ii)  49,936  net  shares  of  common  stock  were  issued  in 
early January 2014 after employees surrendered 15,064 shares for which we paid $92,000 of withholding 
taxes on their behalf. 

Year ended December 31, 2012. No shares of unrestricted stock were granted in 2012, however we granted 
shares of unrestricted common stock in 2010 that affected results for the year ended December 31, 2012. 
Activity in 2012 related to the 2010 stock grant was: i) 2012 stock-based compensation expense included 
$189,000 related to the 2010 grant; and ii) we issued 118,113 net shares of common stock after employees 
surrendered 33,441 shares for which we paid $174,000 of withholding taxes on their behalf.  

54

AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

A summary of stock option transactions for our two fixed stock option plans for the years ended December 
31, 2014, 2013, and 2012 are presented below:  

2014 

2013 

2012 

Outstanding at beginning of year ...  
Granted ..........................................  
Exercised ........................................  
Forfeited or cancelled ....................  
Outstanding at end of year .............   

Shares 
1,004,989 
- 
(117,783) 
(781,004) 
106,202 

Weighted
 Average 
Exercise
Price

$5.68
-
3.98
6.07
$4.71

Weighted 
 Average 
Exercise
Price

$5.63 
- 
4.27 
4.83 
$5.68 

Shares 
1,063,025
-
(6,163)
(51,873)
1,004,989

Shares 
2,835,952
50,000
  (1,779,616)
(43,311)
1,063,025

Weighted
 Average 
Exercise
Price

$4.42
4.60
3.71
4.33
$5.63

Exercisable at year end ..................  

104,117 

$4.69

986,237

$5.70 

1,027,525

$5.66

The number of option shares vested and expected to vest at December 31, 2014 was 106,202 and those options 
had a weighted average exercise price of $4.71. 

No stock options were granted in the years ended December 31, 2014 and 2013. All options granted during the 
year ended December 31, 2012 had exercise prices equal to the fair market value of our common stock on the 
date of grant, and the weighted average grant date fair values of options granted were $2.38.  

At December 31, 2014, the weighted average remaining contractual term for total options outstanding and total 
options exercisable was approximately 2.5 years for each.  

At December 31, 2014, the aggregate intrinsic value of options outstanding and options exercisable was zero 
for each. The intrinsic value of a stock option is the amount by which the market value of the underlying stock 
exceeds  the  exercise  price  of  the  option.    The  aggregate  intrinsic  value  of  options  exercised  during  the  year 
ended December 31, 2014 was approximately $301,000.

The following table summarizes the stock options outstanding at December 31, 2014:  

Exercise Price 
Range 

Number 

Options Outstanding 

Options Exercisable 

Weighted 
Average
Exercise
Price 

Weighted Average 
Remaining 
Contractual 
Term (in years) 

Weighted 
Average
Exercise
Price 

Number 

$2 to $3 
$3 to $4 
$4 to $5 
$6 to $7 

18,000   
14,168   
33,200   
40,834    

106,202  

$2.52 
3.57 
4.64 
6.14  
$4.71  

4.39 
2.82 
2.93 
1.27 
2.52 

18,000 
14,168 
33,200 
38,749     

104,117  

$2.52
3.57
4.64
6.14 
$4.69  

At  December  31,  2014,  unrecognized  compensation  expense  related  to  non-vested  stock  options  was 
approximately $7,000, which is expected to be recognized over a weighted average period of 0.25 years. 

We  issue  common  stock  from  previously  authorized  but  unissued  shares  to  satisfy  option  exercises  and 
purchases under our Employee Stock Purchase Plan. 

Employee  Stock  Purchase  Plan  -  In  June  1996,  we  adopted  an  Employee  Stock  Purchase  Plan  (the  “ESPP 
Plan”) under which eligible employees could purchase common stock at a price equal to 85% of the lower of 
the  fair  market  value  of  the  common  stock  at  the  beginning  or  end  of  each  six-month  offering  period.    On 
November  29,  2005  we  amended  the  ESPP  Plan  to  provide  that  eligible  employees  may  purchase  common 
stock at a price equal to 95% of the fair market value of the common stock as of the end of each six-month 

55

 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
  
   
   
   
   
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

offering period.  There is no stock-based compensation expense related to our Employee Stock Purchase Plan 
because  it  is  not  considered  a  compensatory  plan.  The  plan  does  not  have  a  look-back  feature,  and  has  a 
minimal discount of 5% of the fair market value of the common stock as of the end of each six-month offering 
period.  Participation in the ESPP Plan is limited to 6% of an employee’s compensation, may be terminated at 
any time by the employee and automatically ends on termination of employment.  A total of 350,000 shares of 
common stock have been reserved for issuance.  As of December 31, 2014 there were 100,937 shares available 
for future issuance under the ESPP Plan.  We issued 8,022, 7,196, and 4,661 common shares under the ESPP 
Plan in 2014, 2013, and 2012, respectively. 

Dividends – We paid dividends in the years ended December 31, 2014 and 2012 as follows: 

Year ended December 31, 2014.  On June 26, 2014, our board of directors declared a special cash dividend of 
$1.75 per share. The dividend was paid on July 24, 2014 to shareholders of record as of July 10, 2014.  The 
total dividend payment was $39.9 million. 

Year  ended  December  31,  2012.    In  April  2012,  our  board  of  directors  declared  a  special  cash  dividend  of 
$1.15 per share. The dividend was paid on May 25, 2012 to shareholders of record as of May 11, 2012.  The 
total  amount  of  the  dividend  paid  was  $25.5  million.    In  November  2012, our  board  of  directors  declared  a 
second special cash dividend of $1.80 per share. The dividend was paid on December 17, 2012 to shareholders 
of record as of December 3, 2012.  The total amount of the dividend paid was $40.5 million. 

9.  COMMITMENTS AND CONTINGENT LIABILITIES 

Lease Commitments – We own our principal office and research facility in Bedford, Massachusetts, which we 
have  occupied  since  November  1997.    We  also  conducted  a  portion  of  our  activities  in  a  leased  facility  in 
California in 2012 that we terminated in that year.  Rental expense for the California facility was $0, $0, and 
$25,000 in 2014, 2013 and 2012, respectively. 

Litigation - There are no material pending legal proceedings to which we are a party or to which any of our 
properties are subject which, either individually or in the aggregate, are expected to have a material adverse 
effect on our business, financial position or results of operations. 

Guarantees and Indemnification Obligations – We enter into agreements in the ordinary course of business 
that  require  us:  i)  to  perform  under  the  terms  of  the  contracts,  ii)  to  protect  the  confidentiality  of  our 
customers’ intellectual property, and iii) to indemnify customers, including indemnification against third party 
claims  alleging  infringement  of  intellectual  property  rights.    We  also  have  agreements  with  each  of  our 
directors  and  executive  officers  to  indemnify  such  directors  or  executive  officers,  to  the  extent  legally 
permissible, against all liabilities reasonably incurred in connection with any action in which such individual 
may be involved by reason of such individual being or having been a director or officer of the Company. 

Given the nature of the above obligations and agreements, we are unable to make a reasonable estimate of the 
maximum potential amount that we could be required to pay.  Historically, we have not made any significant 
payments on the above guarantees and indemnifications and no amount has been accrued in the accompanying 
consolidated financial statements with respect to these guarantees and indemnifications. 

56

AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

10.  BUSINESS SEGMENTS AND MAJOR CUSTOMERS 

We organize ourselves into a single segment that reports to the chief operating decision makers. 

We conduct our operations in the United States and sell our products and services to domestic and international 
customers.  Revenues were generated from the following geographic regions (in thousands):  

United States .......................................................
Rest of world ......................................................

Year ended December 31, 

2014 
$18,168 
5,552 
$23,720 

2013 
$13,909 
5,448 
$19,357 

2012 
$12,158 
5,146 
$17,304 

There were no single foreign countries from which we derived 10% or more of total revenue in the years ended 
December 31, 2014, 2013, and 2012. 

Revenue by product group was (in thousands): 

Biometrics ..........................................................
Imaging ...............................................................
DSL royalties ......................................................

Year ended December 31, 

2014 
$21,436 
1,558 
726 
$23,720 

2013 
$17,085 
1,352 
920 
$19,357 

2012 
$13,493 
1,641 
2,170 
$17,304 

The portion of total revenue that was derived from major customers was as follows: 

Customer A   ...................................................  
Customer B   ...................................................  

Year ended December 31, 

2014 
24% 
10% 

2013 
21% 
3% 

2012 
5% 
-% 

11.  EMPLOYEE BENEFIT PLAN 

In 1994, we established a qualified 401(k) Retirement Plan (the “Plan”) under which employees are allowed to 
contribute certain percentages of their pay, up to the maximum allowed under Section 401(k) of the Internal 
Revenue  Code.    Our  contributions  to  the  Plan  are  at  the  discretion  of  the  Board  of  Directors.    Our 
contributions were approximately $198,000, $189,000, and $233,000 in 2014, 2013 and 2012, respectively. 

57

 
 
 
 
 
 
 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

12.  NET INCOME PER SHARE

Net income per share is calculated as follows (in thousands, except per share data):  

Net income: 
   Income from continuing operations ........................................
   Loss from discontinued operations ..........................................
        Net income  ........................................................................

Shares outstanding: 
   Weighted-average common shares outstanding ......................
   Additional dilutive common stock equivalents .......................
   Diluted shares outstanding  .....................................................

 Basic net income per share: 
    Basic net income per share from continuing operations .........
    Basic net loss per share from discontinued operations ...........
         Basic net income per share  ...............................................

 Diluted net income per share: 
    Diluted net income per share from continuing operations ......
    Diluted net loss per share from discontinued operations ........
        Diluted net income per share  .............................................

Year ended December 31, 

2014 

2013 

2012 

$4,583 
- 
$4,583 

22,703 
84 
22,787 

$0.20 
- 
$0.20 

$0.20 
- 
$0.20 

$3,752
(1,156)
$2,596

$72,383
(76)
$72,307

22,543
98
22,641

21,814
257
22,071

$0.17 
(0.05) 
$0.12 

$0.16 
(0.05) 
$0.11 

$3.32 
(0.00) 
$3.32 

$3.28 
(0.00) 
$3.28 

For the years ended December 31, 2014, 2013 and 2012, options to purchase 40,834, 823,338, and 821,838 
shares of common stock at weighted average exercise prices of $6.14, $6.07, and $6.07 per share, respectively, 
were  outstanding,  but  were  not  included in  the  computation  of  diluted  EPS  because  the  options’  exercise 
prices were greater than the average market price of the common shares and thus would be anti-dilutive. 

13.    ACCUMULATED OTHER COMPREHENSIVE LOSS 

The components of accumulated other comprehensive loss and activity were as follows (in thousands): 

December 31, 
2013 

Increase/ 
Decrease 

Reclassification 
Adjustments 

December 31, 
2014 

Unrealized losses on available for sale securities ....................... 
Unrealized gains on available for sale securities ........................ 
   Net unrealized gains (losses) on available for sale securities ... 
Income tax benefit (expense) on other comprehensive loss ........ 
   Total accumulated other comprehensive loss, net of taxes ...... 

($206) 
- 
(206) 
81 
($125) 

$60 
43 
103 
(46) 
$57 

$59 
- 
59  (a) 

(20) 
$39 

($87) 
43 
(44)
15 
($29) 

(a) – Classified in other expense. 

58

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

14.    QUARTERLY RESULTS OF OPERATIONS – UNAUDITED

The following table is a summary of certain items in the consolidated statements of income and comprehensive 
income  for  each  of  our  quarters  in  the  two-year  period  ended  December 31,  2014  (in  thousands,  except  per 
share data).  

March 31 

June 30 

September 30  December 31 

2014 Quarters Ended 

Revenue ................................................
Operating income .................................
Income from continuing operations ......
Income from discontinued operations ..
Net income  ..........................................

$6,617 
              1,311 
880 
- 
880 

Net income per share – basic ................
Net income per share – diluted  ............

$0.04 
$0.04 

$6,767

            1,382  

865
-
865

$0.04
$0.04

$6,027 
  4,155 
2,599 
- 
2,599 

$0.11 
$0.11 

$4,309 
243 
239 
- 
239 

$0.01 
$0.01 

March 31 

June 30 

September 30  December 31 

2013 Quarters Ended 

Revenue ................................................
Operating income .................................
Income from continuing operations ......
Income (loss) from discontinued  
    operations   .......................................
Net income (loss)  .................................

Net income (loss) per share – basic ......
Net income (loss) per share – diluted  ..

$4,979 
              2,982 
1,972 

$4,427 
                 543 
465 

(115) 
1,857 

$0.08 
$0.08 

(158) 
307 

$0.01 
$0.01 

$4,314 
  1,039 
790 

(1,943) 
(1,153) 

($0.05) 
($0.05) 

$5,637 
754 
525 

1,060 
1,585 

$0.07 
$0.07 

Quarterly amounts may not sum to annual amounts due to rounding and dilution. 

15.    OFF-BALANCE SHEET ARRANGEMENTS 

We do not currently have any arrangements with unconsolidated entities, such as entities often referred to as 
structured  finance,  special  purpose  entities,  or  variable  interest  entities  which  are  often  established  for  the 
purpose  of  facilitating  off-balance  sheet  arrangements  or  other  contractually  narrow  or  limited  purposes.  
Accordingly, we are not exposed to any financing, liquidity, market or credit risk if we had such relationships.

In  2011  and  2012,  we  disclosed  that  we  had  a  patent  arrangement  with  an  unaffiliated  third  party  that  we 
classified as a variable interest entity (“VIE”).  Under this arrangement we assigned certain patents to the third 
party,  and  the third  party  engages  in  monetization  activities  and  shares  royalties  with us.    The  third party  is 
engaged  in  the  business  of  the  monetization  of  intellectual  property. We  continue  to  have  a  contractual 
relationship with this third party. 

We  also  disclosed  in  2011  and  2012  that:  i)  we  had  no  equity  interest  in  the  entity;  ii)  we  were  not 
contractually  obligated  to  fund  the  entity,  therefore  our  maximum  exposure  to  loss  as  a  result  of  our 
involvement with the entity was zero; iii) we may receive royalties in the future if certain conditions are met; 
iv) we were not the primary beneficiary of the entity; v) we had not consolidated the entity’s results into our 
financial statements, therefore we carried the assets and liabilities of this entity in our balance sheet at zero; 
and  vi)  prior  to  September  30,  2012,  this  arrangement  had  no  impact  on  our  results  of  operations,  financial 
position or cash flows in any previous periods. 

We determined that the third party entity was a VIE in 2011 and 2012, because we made a judgment that the 
arrangement met two conditions under ASC 810 that caused VIE classification, namely: i) our right to receive 
royalties  entitled  us  to  receive  a  portion  of  the  entity’s  expected  residual  returns;  and  ii)  a  provision  in  the 

59

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AWARE, INC. 
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

agreement  denied  the  equity  holders  of  the  third  party  entity  the  power  to  direct  the  activities  that  most 
significantly impacted the entity’s economic performance. 

We also determined at that time that we were not the primary beneficiary because: i) we had no equity interest 
in the third party entity; and ii) a provision in the agreement resulted in “shared power” that did not give either 
party the power to direct the activities that most significantly impacted the economic performance of the entity.  
Accordingly, we were not required to consolidate the third party entity under ASC 810, because we were not 
the primary beneficiary. 

Due to strategic legal reasons, we found it necessary to amend the agreement in August 2012 to eliminate the 
provision  that  had  previously  denied  the  equity  holders  of  the  third  party  entity  the  power  to  direct  the 
activities that  most significantly impacted  the entity’s economic performance.  Upon amendment, the equity 
holders of the entity had such power, and we determined that the arrangement was no longer a VIE under ASC 
810. 

60

FINANCIAL STATEMENT SCHEDULE 

Schedule II - Valuation and Qualifying Accounts – Years ended December 31, 2014, 2013, and 2012 

(in thousands) 

Col. A 

Col. B 

Col. C(1) 

Col. C(2) 

Col. D 

Col. E 

Additions 

Balance at 
Beginning 
of Period 

Charged to 
Costs and  
Expenses 

Charged  
to Other 
Accounts 

Deductions 
Charged to 
Reserves 

Balance 
at End  
of Period 

$- 
$- 
$- 

$- 
$- 
$- 

$- 
$- 
$- 

$- 
$- 
$- 

$- 
$- 
$10 

$- 
$- 
$1,529 

$- 
$10 
$2 

$- 
$- 
$40,476 

$20 
$20 
$20 

$- 
$- 
$- 

$- 
$- 
$10 

$- 
$- 
$- 

Allowance for doubtful 
accounts receivable: 
   2014 ...........................  
   2013 ...........................  
   2012 ...........................  

Inventory reserves: 
   2014 ...........................  
   2013 ...........................  
   2012 ...........................  

Warranty reserves: 
   2014 ...........................  
   2013 ...........................  
   2012 ...........................  

Deferred tax asset 
valuation allowance: 
   2014 ...........................  
   2013 ...........................  
   2012 ...........................  

$20 
$20 
$30 

$- 
$- 
$1,403 

$- 
$10 
$- 

$- 
$- 
$40,476 

$- 
$- 
$- 

$- 
$- 
$126 

$- 
$- 
$12 

$- 
$- 
$- 

61

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 9.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND 
FINANCIAL DISCLOSURE 

None.  

ITEM 9A.  CONTROLS AND PROCEDURES 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures 

Under the supervision and with the participation of our management, including our co-chief executive officers and 
chief financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined 
under  Rule  13a-15(e)  promulgated  under  the  Securities  Exchange  Act  of  1934,  as  amended  (the  Exchange  Act).  
Based  on  this  evaluation,  our  co-chief  executive  officers  and chief  financial  officer  concluded  that  our  disclosure 
controls and procedures were effective as of the end of the period covered by this annual report.

Evaluation of Changes in Internal Control Over Financial Reporting 

Under the supervision and with the participation of our management, including our co-chief executive officers and 
chief financial officer, we concluded that there were no changes in our internal control over financial reporting that 
occurred  during  the  quarterly  period  ended  December  31,  2014  that  have  materially  affected,  or  are  reasonably 
likely to materially affect, our internal control over financial reporting. 

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as 
defined  in  Rules  13(a)-15(f)  under  the  Exchange  Act.  Under  the  supervision  and  with  the  participation  of  our 
management,  including  our  principal  co-executive  officers  and  principal  financial  officer,  we  conducted  an 
evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal 
Control  -  Integrated  Framework  issued  by  the  Committee  of  Sponsoring  Organizations  of  the  Treadway 
Commission in 2013. Based on our evaluation under the framework in Internal Control — Integrated Framework,
our management concluded that our internal control over financial reporting was effective as of December 31, 2014. 

The  effectiveness  of  our  internal  control  over  financial  reporting  as  of  December 31,  2014  has  been  audited  by 
McGladrey LLP, an independent registered public accounting firm, as stated in their audit report which is included 
herein. 

ITEM 9B.  OTHER INFORMATION 

None. 

62

PART III 

ITEM 10.  DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 

The information required by Item 10 of Form 10-K is incorporated by reference from the information contained in 
the sections captioned “Directors and Executive Officers”, “Corporate Governance” and “Section 16(a) Beneficial 
Ownership Reporting Compliance” in the Proxy Statement that will be delivered to our shareholders in connection 
with our May 20, 2015 Annual Meeting of Shareholders. 

ITEM 11.  EXECUTIVE COMPENSATION 

The information required by Item 11 of Form 10-K is incorporated by reference from the information contained in 
the section captioned “Executive Compensation” in the Proxy Statement that will be delivered to our shareholders in 
connection with our May 20, 2015 Annual Meeting of Shareholders. 

ITEM 12.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND 
RELATED STOCKHOLDER MATTERS 

The information required by Item 12 of Form 10-K is incorporated by reference from the information contained in 
the section captioned “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder 
Matters”  in  the  Proxy  Statement  that  will  be  delivered  to  our  shareholders  in  connection  with  our  May  20,  2015 
Annual Meeting of Shareholders. 

ITEM 13.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR 
INDEPENDENCE 

The  information,  if  any,  required  by  Item  13  of  Form  10-K  is  incorporated  by  reference  from  the  information 
contained  in  the  sections  captioned  “Corporate  Governance”  and  “Certain  Relationships  and  Related 
Transactions”  in  the  Proxy  Statement  that  will  be  delivered  to  our  shareholders  in  connection  with  our  May  20, 
2015 Annual Meeting of Shareholders.  

ITEM 14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES 

The information required by Item 14 of Form 10-K is incorporated by reference from the information contained in 
the section captioned “Independent Accountants” in the Proxy Statement that will be delivered to our shareholders 
in connection with our May 20, 2015 Annual Meeting of Shareholders. 

63

PART IV 

ITEM 15.  EXHIBITS AND FINANCIAL STATEMENT SCHEDULE 

The following documents are filed as part of this report: 

(a) Financial Statements and Exhibits:

(1) Consolidated Balance Sheets as of December 31, 2014 and 2013 ..............................  
Consolidated Statements of Income and Comprehensive Income for each of the three 
    years in the period ended December 31, 2014 ..............................................................  
Consolidated Statements of Cash Flows for each of the  
    three years in the period ended December 31, 2014 .....................................................   
Consolidated Statements of Stockholders’ Equity for each of 
     the three years in the period ended December 31, 2014 ..............................................   
Notes to Consolidated Financial Statements .....................................................................   
(2) Schedule II - Valuation and Qualifying Accounts ......................................................  

    (3) Exhibits: 

The exhibits listed below are filed with or incorporated by reference in this report. 

Page 

39 

40 

41 

42 
43 
61 

Exhibit No. 
3.1 

3.2 

10.1*  

10.2* 

10.3* 

10.4* 

10.5* 

10.6* 

10.7* 

10.8* 

10.9 

Description of Exhibit
Amended and Restated Articles of Organization, as amended (filed as Exhibit 3.1 to the 
Company’s Form 10-K for the year ended December 31, 2008 and incorporated herein 
by reference).  
Amended and Restated By-Laws (filed as Exhibit 3.1 to the Company’s Form 8-K filed 
with the Securities and Exchange Commission on December 10, 2007 and incorporated 
herein by reference). 
1996 Stock Option Plan, as amended and restated (filed as Annex A to the Company’s 
Definitive Proxy Statement filed with the Securities and Exchange Commission on April 
11, 2000 and incorporated herein by reference). 
1996 Employee Stock Purchase Plan, as amended and restated (filed as Exhibit 99.1 to 
the  Company’s  Current  Report  on  Form  8-K  filed  with  the  Securities  and  Exchange 
Commission on November 29, 2005 and incorporated herein by reference). 
Form of Indemnification Agreement for Directors and Officers of Aware, Inc. (filed as 
Exhibit  10.1  to  the  Company's  Form  8-K  filed  with  the  Securities  and  Exchange 
Commission on February 22, 2011 and incorporated herein by reference). 
2001 Nonqualified Stock Plan (filed as Exhibit 99(d)(4) to the Company’s Schedule TO 
filed with the Securities and Exchange Commission on March 3, 2003 and incorporated 
herein by reference). 
Form of Nonqualified Stock Option Agreement under the 2001 Nonqualified Stock Plan 
for  options  granted  to  executive  officers  and  directors  prior  to  May  21,  2008  (filed  as 
Exhibit  10.6  to  Company’s  Form  10-K  for  the  year  ended  December  31,  2006  and 
incorporated herein by reference). 
Form of Nonqualified Stock Option Agreement under the 2001 Nonqualified Stock Plan 
for options granted to executive officers and directors from and after May 21, 2008 (filed 
as  Exhibit  10.8  to  Company’s  Form  8-K  on  May  22,  2008  and  incorporated  herein  by 
reference) 
Form  of  Unrestricted  Stock  Award  for  outside  directors  of  Aware  under  the  2001 
Nonqualified  Stock  Plan  (filed  as  Exhibit  10.1  to  Company's  Form  8-K  filed  with  the 
Securities  and  Exchange  Commission  on  July  28,  2010  and  incorporated  herein  by 
reference). 
Form  of  Unrestricted  Stock Award for  officers  of  Aware  under  the 2001  Nonqualified 
Stock Plan (filed as Exhibit 10.2 to Company's Form 8-K filed with the Securities and 
Exchange Commission on July 28, 2010 and incorporated herein by reference). 
Asset Purchase Agreement by and between Aware, Inc. and Lantiq Broadband Holdco, 
Inc.  and  Lantiq  Deutschland  GmbH  dated  October  14,  2009  (filed  as  Exhibit  10.8  to 

64

10.12* 

21.1 
23.1 
31.1 

31.2 

32.1 

101** 

Company’s Form 10-K for the year ended December 31, 2009 and incorporated herein 
by reference). 
Form  of  Unrestricted  Stock  Award  for  executive  officers  and  directors  of  Aware,  Inc. 
under  the  2001  Nonqualified  Plan  (filed  as  Exhibit  10.1  to  the  Company’s  Form  8-K 
filed with  the Securities  and Exchange  Commission on April  4, 2013 and  incorporated 
herein by reference).  
Subsidiaries of Registrant. 
Consent of Independent Registered Public Accounting Firm. 
Certification  of  co-Chief  Executive  Officer  pursuant  to  Section  302  of  the  Sarbanes-
Oxley Act of 2002. 
Certification  of  co-Chief  Executive  Officer  and  Chief  Financial  Officer  pursuant  to 
Section 302 of the Sarbanes-Oxley Act of 2002. 
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 
906 of the Sarbanes-Oxley Act of 2002. 
The following financial statements from Aware, Inc.’s Annual Report on Form 10-K for 
the year ended December 31, 2014, formatted in XBRL (eXtensible Business Reporting 
Language),  as  follows:  (i)  Consolidated  Balance  Sheets  as  of  December  31,  2014  and 
December 31, 2013; (ii) Consolidated Statements of Income and Comprehensive Income 
for the Years Ended December 31, 2014, December 31, 2013 and December 31, 2012; 
(iii)  Consolidated  Statements  of  Cash  Flows  for  the  Years  Ended  December  31,  2014, 
December  31,  2013  and  December  31,  2012;  (iv)  Consolidated  Statements  of 
Stockholders’ Equity for the Years Ended December 31, 2014, December 31, 2013 and 
December 31, 2012; and (v) Notes to Consolidated Financial Statements.  

†Portions  of  this  exhibit  are  omitted  and  were  filed  separately  with  the  Securities  and  Exchange  Commission 
pursuant  to  the  Company’s  application  requesting  confidential  treatment  under  Rule  24b-2  of  the  Securities 
Exchange Act of 1934, as amended. 

*Management contract or compensatory plan. 

**Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto shall not be deemed 
filed for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities 
Exchange Act of 1934, as amended, or otherwise subject to liability under those sections. 

65

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly 
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

SIGNATURES 

AWARE, INC. 

                                                                                                           General Counsel 

By:  /s/  Kevin T. Russell 

                  Kevin T. Russell 

       co-Chief Executive Officer & co-President 

By:  /s/  Richard P. Moberg 
        Richard P. Moberg  
        co-Chief Executive Officer & co-President 

                   Chief Financial Officer (Principal Financial and                           

                       Accounting Officer) 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the 
following persons on behalf of the registrant and in the capacities indicated on the 13th day of February 2015. 

Date: February 13, 2015 

Signature 

/s/ Kevin T. Russell 
Kevin T. Russell 

/s/ Richard P. Moberg 
Richard P. Moberg 

/s/ John S. Stafford, Jr. 
John S. Stafford, Jr. 

/s/ John S. Stafford, III 
John S. Stafford, III 

/s/ Adrian F. Kruse 
Adrian F. Kruse 

/s/ Brian D. Connolly  
Brian D. Connolly 

/s/ Brent P. Johnstone  
Brent P. Johnstone 

Title 

co-Chief Executive Officer, co-President, 
General Counsel & Director 
(co-Principal Executive Officer) 

co-Chief Executive Officer, co-President, 
Chief Financial Officer & Director 
(co-Principal Executive Officer) 
(Principal Financial and Accounting Officer) 

Chairman of the Board & Director 

Director 

Director  

Director 

Director 

66

                  
 
                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(cid:3)

Corpora te I nfo r mat io n

BOARD OF DIRECTORS 

LEGAL COUNSEL 

John S. Stafford, Jr. 
Chairman
Investor 

John S. Stafford, III 
Investor

Adrian F. Kruse, C.P.A., J.D. 
Audit Partner (retired) 
Ernst & Young LLP

Brent P. Johnstone
Managing Director
Quarry Capital Management, LLC

Brian D. Connolly 
Portfolio Manager 
Millstreet Capital Management, LLC

Richard P. Moberg
co-Chief  Executive Officer & co-President
Chief  Financial Officer
Aware, Inc.

Kevin T. Russell
co-Chief  Executive Officer & co-President
General Counsel 
Aware, Inc.

OFFICERS 
Richard P. Moberg
co-Chief  Executive Officer & co-President
Chief  Financial Officer

Kevin T. Russell
co-Chief  Executive Officer & co-President
General Counsel

Foley Hoag LLP  
Boston, MA 

INDEPENDENT REGISTERED   
PUBLIC ACCOUNTING FIRM

McGladrey LLP 
Boston, MA 

TRANSFER AGENT 

Computershare Trust Company, N.A. 
PO Box 43078 
Providence, RI 02940-3078 
(877) 282-1168 
www.computershare.com 

ANNUAL MEETING 
Wednesday, 10:00 a.m. 
May 20, 2015
Aware, Inc.
Bedford, MA 

STOCK LISTING 
NASDAQ: AWRE 

CORPORATE HEADQUARTERS 

40 Middlesex Turnpike 
Bedford, MA 01730 
(781) 276-4000 

CONTACT INFORMATION 

Investor Relations 
Aware, Inc. 
40 Middlesex Turnpike 
Bedford, MA 01730-1432 USA 
(781) 276-4000 
www.aware.com 

Aware, Inc., 40 Middlesex Turnpike, Bedford, MA  01730-1432 USA

T (781) 276-4000    |    F (781) 276-4001    |    www.aware.com